conversations
listlengths 3
57
|
|---|
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the percentage of oxygen?"
},
{
"from": "gpt",
"value": "The percentage of oxygen (inO2) is consistently 71% across the five data points."
},
{
"from": "human",
"value": "Are there any readings for nitrous oxide (inN2O) in the data?"
},
{
"from": "gpt",
"value": "No, there are no readings for nitrous oxide (inN2O) in the data. All readings are 0%."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "Do you have stents in any artery in your brain or body?"
},
{
"from": "gpt",
"value": "No, I do not have stents in any artery in my brain or body."
},
{
"from": "human",
"value": "Have you ever had a heart attack or cardiac bypass operation?"
},
{
"from": "gpt",
"value": "No, I have not."
},
{
"from": "human",
"value": "What action should you take if you do have stents in an artery in your brain or body?"
},
{
"from": "gpt",
"value": "If you have stents in an artery in your brain or body, you should ask your surgeon to complete a \"Stent Letter\"."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's head, ears, nose, and throat (HENT) symptoms?"
},
{
"from": "gpt",
"value": "The patient's HENT symptoms (congestion) are negative."
},
{
"from": "human",
"value": "What is the name of the medication being used, and what form is it in?"
},
{
"from": "gpt",
"value": "The medication being used is triamcinolone, and it is in a cream form."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's respiratory symptoms?"
},
{
"from": "gpt",
"value": "The patient's respiratory symptoms (cough, shortness of breath, and wheezing) are negative."
},
{
"from": "human",
"value": "How often is the medication being applied?"
},
{
"from": "gpt",
"value": "The medication is being applied 2 times a day, as needed (PRN)."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's musculoskeletal symptoms?"
},
{
"from": "gpt",
"value": "The patient's musculoskeletal symptoms are negative."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's cardiovascular symptoms?"
},
{
"from": "gpt",
"value": "The patient's cardiovascular symptoms (chest pain) are negative."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's gastrointestinal symptoms?"
},
{
"from": "gpt",
"value": "The patient's gastrointestinal symptoms (diarrhea, nausea, and vomiting) are negative."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's neurological symptoms?"
},
{
"from": "gpt",
"value": "The patient's neurological symptoms (dizziness) are negative."
},
{
"from": "human",
"value": "What is the result of the examination of the patient's constitutional symptoms?"
},
{
"from": "gpt",
"value": "The patient's constitutional symptoms (fevers, appetite change, chills, and fatigue) are negative."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What medication was added to the treatment regimen on December 20, 2024, and what was the dosage?"
},
{
"from": "gpt",
"value": "Pertuzumab (PERJETA) was added to the treatment regimen, and the dosage was 420 mg."
},
{
"from": "human",
"value": "What is the patient's current height and weight?"
},
{
"from": "gpt",
"value": "The patient's height is 157.5 cm, and their weight is 59.8 kg."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What medication was prescribed for breakthrough nausea/vomiting, and why was it discontinued?"
},
{
"from": "gpt",
"value": "The medication prescribed for breakthrough nausea/vomiting was prochlorperazine 10 MG Tablet. It was discontinued because the patient was not responding to it."
},
{
"from": "human",
"value": "What is the treatment plan for the patient's breast cancer, and what is the frequency of the treatment?"
},
{
"from": "gpt",
"value": "The treatment plan is called TCHP Neoadjuvant, and it has two frequencies: Q8 Hrs PRN from 07/11/24 to 08/05/24 and Q6 Hrs PRN from 07/11/24 to 08/05/24."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the global longitudinal strain of the left ventricle, as measured on Philips Affiniti?"
},
{
"from": "gpt",
"value": "The global longitudinal strain of the left ventricle is normal, measuring -21.0%."
},
{
"from": "human",
"value": "Is there significant aortic regurgitation present?"
},
{
"from": "gpt",
"value": "No, there is no significant aortic regurgitation present."
},
{
"from": "human",
"value": "What is the estimated ejection fraction of the left ventricle?"
},
{
"from": "gpt",
"value": "The estimated ejection fraction of the left ventricle is between 55-60%."
},
{
"from": "human",
"value": "What is the size of the right ventricle?"
},
{
"from": "gpt",
"value": "The right ventricle is normal in size."
},
{
"from": "human",
"value": "What is the assessment of the left ventricle's diastolic function?"
},
{
"from": "gpt",
"value": "The left ventricle's diastolic function is normal, and the filling pressures are also normal."
},
{
"from": "human",
"value": "What is the size of the left ventricle?"
},
{
"from": "gpt",
"value": "The left ventricle is normal in size."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the wound classification after the surgery?"
},
{
"from": "gpt",
"value": "The wound classification is Class I."
},
{
"from": "human",
"value": "When is Sucharitra Lama's follow-up appointment scheduled?"
},
{
"from": "gpt",
"value": "Her follow-up appointment is scheduled for one week in the office with Dr. Chang."
},
{
"from": "human",
"value": "What is the reason for the surgery that Sucharitra Lama is undergoing?"
},
{
"from": "gpt",
"value": "Sucharitra Lama is having surgery for a personal history of malignant neoplasm of the breast, as well as a deformity and disproportion of the reconstructed breast."
},
{
"from": "human",
"value": "What procedure was performed during the surgery?"
},
{
"from": "gpt",
"value": "The procedure involved fat retrieval from the abdomen and fat grafting of approximately 120 mL to both the right and left breast."
},
{
"from": "human",
"value": "What is the contact information for Dr. Chang's office?"
},
{
"from": "gpt",
"value": "The contact information is a phone number: 516-724-3404, and a voicemail option."
},
{
"from": "human",
"value": "What instructions were given to Sucharitra Lama for her post-operative care?"
},
{
"from": "gpt",
"value": "She was instructed to avoid tight clothing or bras, pressure on the bilateral reconstructed breasts, and heavy lifting. She was also advised to shower below the waist and sponge bathe above, wear an abdominal binder as much as possible below the breasts, take medications as directed, and keep all dressings in place."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What type of information is involved in the evaluation process that the physician must complete before making a decision?"
},
{
"from": "gpt",
"value": "The evaluation process involves both clinical and laboratory findings."
},
{
"from": "human",
"value": "What type of information might be provided as a result of the evaluation process?"
},
{
"from": "gpt",
"value": "Additional resulting lab information might be provided."
},
{
"from": "human",
"value": "When can a certain action or decision be made by a physician?"
},
{
"from": "gpt",
"value": "The physician can make the decision or action only after all clinical and laboratory findings have been evaluated."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What are the indications for giving famotidine (PEPCID) injection 20mg, and how should it be administered?"
},
{
"from": "gpt",
"value": "The indications for giving famotidine (PEPCID) injection 20mg are for mucocutaneous symptoms (flushing, hives, itching), respiratory symptoms (dyspnea, wheezing, bronchospasm, stridor, oxygen saturation <90%), and/or >30% reduction in blood pressure from baseline caused by an infusion reaction. It should be administered by diluting to a maximum concentration of 4 mg/mL and may be given I.V. push at 10 mg/minute."
},
{
"from": "human",
"value": "What is the purpose of administering methylPREDNISolone sod suc (SOLU-Medrol) injection 125mg, and what are the indications for giving this medication?"
},
{
"from": "gpt",
"value": "The purpose of administering methylPREDNISolone sod suc (SOLU-Medrol) injection 125mg is to treat mucocutaneous symptoms (flushing, hives, itching), respiratory symptoms (dyspnea, wheezing, bronchospasm, stridor, oxygen saturation <90%), and/or >30% reduction in blood pressure from baseline caused by an infusion reaction. It should be given in combination with other prn medications for the same indication."
},
{
"from": "human",
"value": "What is the purpose of administering diphenhydramine 25mg, and what are the common side effects of this medication?"
},
{
"from": "gpt",
"value": "The purpose of administering diphenhydramine 25mg is to treat persistent symptoms after the first dose of diphenhydramine. The common side effects of this medication include drowsiness, dry mouth, and dry eyes."
},
{
"from": "human",
"value": "Who is responsible for authorizing the administration of medications?"
},
{
"from": "gpt",
"value": "The ordering provider, Murthy, Pooja, MD, is responsible for authorizing the administration of medications."
},
{
"from": "human",
"value": "What are the common side effects of methylPREDNISolone sod suc (SOLU-Medrol) injection 125mg?"
},
{
"from": "gpt",
"value": "The common side effects of methylPREDNISolone sod suc (SOLU-Medrol) injection 125mg include dizziness and headache."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What are the common side effects of oxyCODONE (ROXICODONE) immediate release tablets?"
},
{
"from": "gpt",
"value": "The common side effects of oxyCODONE (ROXICODONE) immediate release tablets include feeling dizzy, tired, or weak, dry mouth, constipation, and itching."
},
{
"from": "human",
"value": "What is the date on which a patient was admitted to the hospital, and what is their discharge date?"
},
{
"from": "gpt",
"value": "The patient was admitted on January 8, 2025, and their discharge date is January 9, 2025."
},
{
"from": "human",
"value": "What is the reason for the discontinuation of the ondansetron medication, and what is the status of the medication?"
},
{
"from": "gpt",
"value": "The ondansetron medication was discontinued because the patient was transferred. The status of the medication is \"Discontinued (Past End Date/Time)\"."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What are some common side effects of the medication ondansetron (ZOFRAN)?"
},
{
"from": "gpt",
"value": "Common side effects of ondansetron (ZOFRAN) include headache, slow heart rate, and constipation."
},
{
"from": "human",
"value": "What are some precautions that should be taken when administering the medication dexamethasone (DECADRON) 10 MG/ML injection?"
},
{
"from": "gpt",
"value": "When administering dexamethasone (DECADRON) 10 MG/ML injection, it is recommended to use a dose of less than or equal to 10 mg."
},
{
"from": "human",
"value": "What is the purpose of the medication ondansetron (ZOFRAN) 2 MG/ML injection, and how should it be administered?"
},
{
"from": "gpt",
"value": "The medication ondansetron (ZOFRAN) 2 MG/ML injection is intended for IV Push over a pre-specified duration, and it should not be used as an IV piggyback."
},
{
"from": "human",
"value": "What are some potential side effects of the medication dexamethasone (DECADRON)?"
},
{
"from": "gpt",
"value": "Potential side effects of dexamethasone (DECADRON) include elevated blood sugar, increased blood pressure, and irritability."
},
{
"from": "human",
"value": "What is the status of the medication propofol (DIPRIVAN) 10 mg/mL injection?"
},
{
"from": "gpt",
"value": "The medication propofol (DIPRIVAN) 10 mg/mL injection is currently active and has been ordered by Interface, Ads on 05/28/25 0824."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the recommended administration method for a specific medication, and what should be avoided?"
},
{
"from": "gpt",
"value": "The medication should be administered via IV Push over a specified duration, and IV Piggyback should not be used."
},
{
"from": "human",
"value": "What is the recommended dose and frequency of administration for a specific medication, and what is the class of the order?"
},
{
"from": "gpt",
"value": "The medication should be given once PRN, and the class of the order is Normal."
},
{
"from": "human",
"value": "How should a specific medication be reconstituted, and what should be done with any unused portion?"
},
{
"from": "gpt",
"value": "The medication should be reconstituted with 2 mL of sterile water for injection to give a concentration of approximately 62.5 mg/mL. Any unused portion should be discarded."
},
{
"from": "human",
"value": "What are the indications for giving a specific medication, and what should it be given in combination with?"
},
{
"from": "gpt",
"value": "This medication should be given for mucocutaneous symptoms, respiratory symptoms, and/or a >30% reduction in blood pressure from baseline caused by an infusion reaction. It should be given in combination with other PRN medications for the same indication."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the purpose of administering diphenhydrAMINE (BENADRYL) injection?"
},
{
"from": "gpt",
"value": "DiphenhydrAMINE (BENADRYL) injection is given to alleviate symptoms caused by an infusion reaction, including mucocutaneous symptoms (such as flushing, hives, and itching) and respiratory symptoms (such as dyspnea, wheezing, bronchospasm, and stridor)."
},
{
"from": "human",
"value": "What is the instruction for administering diphenhydrAMINE (BENADRYL) injection?"
},
{
"from": "gpt",
"value": "DiphenhydrAMINE (BENADRYL) injection should be given as a second dose for persistent symptoms after the first dose of 25mg. It is intended to be administered via IV Push over a specified duration, and should not be used via IV piggyback."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the diagnosis for the patient's condition?"
},
{
"from": "gpt",
"value": "The patient has been diagnosed with a malignant neoplasm of overlapping sites of the left breast in a female, which is estrogen receptor positive (C50.812, Z17.0), and a urinary tract infection without hematuria, site unspecified (N39.0)."
},
{
"from": "human",
"value": "What is the purpose of the Urine Culture test, and what was the final result?"
},
{
"from": "gpt",
"value": "The Urine Culture test was performed to identify any bacteria or other pathogens present in the patient's urine. The final result of the test was \"No growth\", indicating that no bacteria or other pathogens were detected in the urine sample."
},
{
"from": "human",
"value": "What medication was ordered for the patient, and what was its status?"
},
{
"from": "gpt",
"value": "The patient was ordered to receive albuterol (2.5 MG/3ML) 0.083% nebulizer solution, but the order was cancelled and held."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the status of the order for methylPREDNISolone sod suc (SOLU-Medrol) injection?"
},
{
"from": "gpt",
"value": "The order for methylPREDNISolone sod suc (SOLU-Medrol) injection is Cancel Held, meaning that it may be acted on in another encounter."
},
{
"from": "human",
"value": "Who authorized the ordering of methylPREDNISolone sod suc (SOLU-Medrol) injection?"
},
{
"from": "gpt",
"value": "The ordering provider, Murthy, Pooja, MD, authorized the ordering of methylPREDNISolone sod suc (SOLU-Medrol) injection."
},
{
"from": "human",
"value": "What is the status of the order for acetaminophen (TYLENOL) tablet?"
},
{
"from": "gpt",
"value": "The order for acetaminophen (TYLENOL) tablet is Cancel Held, meaning that it may be acted on in another encounter."
},
{
"from": "human",
"value": "What is the indication for use of acetaminophen (TYLENOL) tablet in this case?"
},
{
"from": "gpt",
"value": "The indication for use of acetaminophen (TYLENOL) tablet is to treat a temperature >38.3C caused by an infusion reaction."
},
{
"from": "human",
"value": "What are the common side effects of methylPREDNISolone sod suc (SOLU-Medrol) injection?"
},
{
"from": "gpt",
"value": "The common side effects of methylPREDNISolone sod suc (SOLU-Medrol) injection include dizziness and headache."
},
{
"from": "human",
"value": "How should methylPREDNISolone sod suc (SOLU-Medrol) injection be administered?"
},
{
"from": "gpt",
"value": "MethylPREDNISolone sod suc (SOLU-Medrol) injection should be administered I.V. push at a rate of 10 mg/minute. It should be refrigerated and diluted to a maximum concentration of 4 mg/mL."
},
{
"from": "human",
"value": "What is the purpose of administering methylPREDNISolone sod suc (SOLU-Medrol) injection in this case?"
},
{
"from": "gpt",
"value": "The purpose of administering methylPREDNISolone sod suc (SOLU-Medrol) injection is to treat infusion-related reactions, including mucocutaneous symptoms (such as flushing, hives, and itching), respiratory symptoms (such as dyspnea, wheezing, bronchospasm, stridor, and oxygen saturation <90%), and/or a >30% reduction in blood pressure from baseline."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the patient's genetic testing result, and what does it indicate?"
},
{
"from": "gpt",
"value": "The patient's genetic testing has come back negative, indicating that there are no inherited genetic mutations associated with an increased risk of breast cancer."
},
{
"from": "human",
"value": "What is the patient's current plan, and what follow-up appointments have been scheduled?"
},
{
"from": "gpt",
"value": "The patient has been scheduled to follow up in person in 2 weeks for next steps, and a 6-month follow-up breast ultrasound (US) is planned for BR 3 findings. The patient has also been referred to a plastic surgeon (Jerry Chang) and a medical oncologist (Pooja Murthy)."
},
{
"from": "human",
"value": "What is the patient's understanding of their treatment options, and what was discussed with them?"
},
{
"from": "gpt",
"value": "The patient understands that chemotherapy/targeted therapy may be recommended prior to surgery, and they were given the opportunity to ask questions, which were all answered."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the recommended administration method for this medication?"
},
{
"from": "gpt",
"value": "The medication is intended to be given as an IV Push over a pre-specified duration, and should not be used as an IV piggyback."
},
{
"from": "human",
"value": "What is the purpose of the medication diphenhydrAMINE (BENADRYL) injection 25 mg?"
},
{
"from": "gpt",
"value": "The medication diphenhydrAMINE (BENADRYL) injection 25 mg is intended to be given for mucocutaneous symptoms (such as flushing, hives, and itching), respiratory symptoms (such as dyspnea, wheezing, bronchospasm, stridor, and oxygen saturation less than 90%), and/or a greater than 30% reduction in blood pressure from baseline caused by an infusion reaction."
},
{
"from": "human",
"value": "What is the frequency of administration for this medication?"
},
{
"from": "gpt",
"value": "The medication is to be given once, as needed (PRN), in response to the onset of symptoms."
},
{
"from": "human",
"value": "What are some common side effects of diphenhydrAMINE (BENADRYL) injection 25 mg?"
},
{
"from": "gpt",
"value": "Common side effects of diphenhydrAMINE (BENADRYL) injection 25 mg include drowsiness, dry mouth, and dry eyes."
},
{
"from": "human",
"value": "Who discontinued this medication order?"
},
{
"from": "gpt",
"value": "The medication order was discontinued by Oh, Jane, RN on July 24, 2025 at 10:37."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the age and menopausal status of the patient being described?"
},
{
"from": "gpt",
"value": "The patient is 41 years old and premenopausal."
},
{
"from": "human",
"value": "What is the patient's imaging diagnosis, including the size and location of the tumor?"
},
{
"from": "gpt",
"value": "The patient's imaging diagnosis includes:\n\n* A 2.8cm mass at 6:00 on ultrasound (US).\n* A segment of non-mass enhancement (NME) on MRI, spanning 7.1 x 2.6 x 3.3 cm.\n* The NME is located at 5-8:00 on the left breast."
},
{
"from": "human",
"value": "What types of treatment were discussed with the patient?"
},
{
"from": "gpt",
"value": "The patient was discussed the following types of treatment:\n\n* Overview of breast cancer treatment\n* Systemic therapy, including hormonal therapy and chemotherapy/targeted treatment."
},
{
"from": "human",
"value": "What are the results of the patient's genetic testing?"
},
{
"from": "gpt",
"value": "The patient's genetic testing is negative for any adverse findings."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What was the outcome of the patient's consultation with the healthcare provider, and what are the next steps in their care?"
},
{
"from": "gpt",
"value": "The patient was fully informed of the risks and benefits of the surgery, and their questions were answered. The patient is in agreement to proceed with the surgery, and they will be undergoing the procedure in the operating room today. The patient has also been cleared by their primary care physician, and they will be following up with plastic surgery afterwards."
},
{
"from": "human",
"value": "What type of surgery is the patient interested in, and what are the potential risks and complications associated with this surgery?"
},
{
"from": "gpt",
"value": "The patient is interested in undergoing bilateral nipple-sparing mastectomies with left sentinel lymph node biopsy, possible axillary lymph node dissection, and reconstruction/plastic surgery. The potential risks and complications associated with this surgery include infection, bleeding, hematoma, seroma, positive margins requiring further surgery, poor cosmesis, chronic pain, paresthesias, breast and nipple numbness, and wound complications."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What was the outcome of the patient's discussion with the medical team, and what was the next step for the patient?"
},
{
"from": "gpt",
"value": "The patient decided to undergo neoadjuvant chemotherapy (NACT)."
},
{
"from": "human",
"value": "What alternative approach to treatment was discussed with the patient, and what would be the outcome of this approach?"
},
{
"from": "gpt",
"value": "The patient was also informed that she could undergo surgery first, without neoadjuvant chemotherapy. The final pathology results after surgery would then dictate further systemic treatment."
},
{
"from": "human",
"value": "What surgical options were discussed with the patient, and what were the patient's preferences?"
},
{
"from": "gpt",
"value": "The patient was interested in bilateral possible nipple-sparing mastectomies with lymphatic mapping sentinel lymph node biopsy (L SLNB) and reconstruction. The patient had met with a plastic surgery doctor to discuss these options."
},
{
"from": "human",
"value": "What benefits of neoadjuvant chemotherapy (NACT) were discussed with the patient?"
},
{
"from": "gpt",
"value": "The benefits of NACT discussed with the patient included possible less axillary surgery and results that could inform adjuvant treatment recommendations per medical oncology."
},
{
"from": "human",
"value": "What was the recommendation regarding breast conservation surgery after discussing the extent of disease and NME (node metastasis) of the patient's cancer?"
},
{
"from": "gpt",
"value": "Due to the extent of disease and NME, it was not thought that NACT would facilitate breast conservation surgery, and a mastectomy of the left breast was recommended."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the patient's current level of independence in dressing themselves?"
},
{
"from": "gpt",
"value": "The patient is currently independent in dressing themselves."
},
{
"from": "human",
"value": "What is the patient's current level of independence in feeding themselves?"
},
{
"from": "gpt",
"value": "The patient is currently independent in feeding themselves."
},
{
"from": "human",
"value": "How is the patient's hearing in their right ear?"
},
{
"from": "gpt",
"value": "The patient has functional hearing in their right ear."
},
{
"from": "human",
"value": "What is the patient's current level of ability to move their extremities?"
},
{
"from": "gpt",
"value": "The patient is currently able to move their extremities voluntarily or on command."
},
{
"from": "human",
"value": "What is the patient's current level of oxygen saturation?"
},
{
"from": "gpt",
"value": "The patient's oxygen saturation is greater than 90%."
},
{
"from": "human",
"value": "What is the patient's current Modified Aldrete score?"
},
{
"from": "gpt",
"value": "The patient's current Modified Aldrete score is 8."
},
{
"from": "human",
"value": "Does the patient have any identified barriers to discharge?"
},
{
"from": "gpt",
"value": "No, the patient does not have any identified barriers to discharge."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the diameter of the aortic root, as measured on 5/12/2025?"
},
{
"from": "gpt",
"value": "The diameter of the aortic root is 3.2 cm."
},
{
"from": "human",
"value": "What is the patient's left ventricular ejection fraction, as measured on 5/12/2025?"
},
{
"from": "gpt",
"value": "The patient's left ventricular ejection fraction is 67.2%."
},
{
"from": "human",
"value": "What is the patient's height, as recorded on 5/12/2025?"
},
{
"from": "gpt",
"value": "The patient's height is 157.5 cm."
},
{
"from": "human",
"value": "What is the left ventricular end-systolic volume, as measured using the modified 2CH method?"
},
{
"from": "gpt",
"value": "The left ventricular end-systolic volume is 29.3 cm^3."
},
{
"from": "human",
"value": "What is the patient's systolic blood pressure, as measured on 5/12/2025?"
},
{
"from": "gpt",
"value": "The patient's systolic blood pressure is 111 mmHg."
},
{
"from": "human",
"value": "What is the patient's body mass index (BMI), as calculated using the Haycock formula?"
},
{
"from": "gpt",
"value": "The patient's BMI is 24.5."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the history of the patient's breast cancer diagnosis?"
},
{
"from": "gpt",
"value": "The patient's breast cancer diagnosis began with the discovery of calcifications in the left lower inner quadrant on March 4, 2024. On April 1, 2024, a stereotactic biopsy was recommended due to fine pleomorphic calcifications in the left breast. The biopsy results showed invasive poorly differentiated ductal carcinoma measuring 7 mm in greatest length."
},
{
"from": "human",
"value": "What is the recommendation for further evaluation if mastectomy is not planned?"
},
{
"from": "gpt",
"value": "If mastectomy is not planned, MRI-guided biopsy of the posterior extent of the enhancement is recommended to document the extent of the disease."
},
{
"from": "human",
"value": "What is the purpose of the MRI-guided biopsy?"
},
{
"from": "gpt",
"value": "The purpose of the MRI-guided biopsy is to document the extent of the disease in the patient's breast."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What surgical procedures has the patient undergone?"
},
{
"from": "gpt",
"value": "The patient has undergone the following surgical procedures:\n\n* A breast biopsy of the left breast in May 2024\n* A hysterectomy with polypectomy in August 2025\n* An identification of sentinel nodes, bilateral, in January 2025\n* A simple mastectomy, bilateral, in January 2025"
},
{
"from": "human",
"value": "Does the patient have any known allergies?"
},
{
"from": "gpt",
"value": "No, the patient does not have any known allergies."
},
{
"from": "human",
"value": "What medications is the patient currently taking?"
},
{
"from": "gpt",
"value": "The patient is currently taking the following medications:\n\n* Buspirone 5 mg tablets (although the patient reports not taking them)\n* Clindamycin phosphate 1% cream to be applied topically twice a day\n* Hydrocortisone 1% cream to be applied topically twice a day\n* Ketoconazole 2% shampoo to be applied topically twice a week\n* Tamoxifen citrate 20 mg tablets to be taken daily (the patient is taking two separate prescriptions for this medication)\n* Triamcinolone 0.1% cream to be applied topically twice a day as needed"
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What was the patient's age and menopausal status at the time of her diagnosis?"
},
{
"from": "gpt",
"value": "The patient was 41 years old and premenopausal at the time of her diagnosis."
},
{
"from": "human",
"value": "Who was the patient's primary care provider?"
},
{
"from": "gpt",
"value": "The patient's primary care provider was Binh Lam, MD."
},
{
"from": "human",
"value": "What was the result of the patient's bilateral screening mammogram on 3/4/2024?"
},
{
"from": "gpt",
"value": "The bilateral screening mammogram showed calcifications in the left breast, lower inner quadrant."
},
{
"from": "human",
"value": "How long did the patient's visit on 8/15/2024 last?"
},
{
"from": "gpt",
"value": "The patient's visit on 8/15/2024 lasted 22 minutes."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "Who performed the chemotherapy infusion on October 10, 2024?"
},
{
"from": "gpt",
"value": "The chemotherapy infusion was performed by Jane, RN."
},
{
"from": "human",
"value": "What was the reason for the patient's chemotherapy treatment?"
},
{
"from": "gpt",
"value": "The patient had a malignant neoplasm of overlapping sites of the left breast, and the chemotherapy treatment was being used as a neoadjuvant treatment."
},
{
"from": "human",
"value": "Who signed off on the IV access order on August 8, 2024?"
},
{
"from": "gpt",
"value": "Tenzin, NP signed off on the IV access order on August 8, 2024."
},
{
"from": "human",
"value": "When was the patient discharged?"
},
{
"from": "gpt",
"value": "The patient was discharged on October 11, 2024, at 04:49."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What was the result of the stereotactic biopsy?"
},
{
"from": "gpt",
"value": "The biopsy results showed invasive poorly differentiated ductal carcinoma measuring 7 mm in greatest length, as well as ductal carcinoma in situ (DCIS) with high nuclear grade, solid type, necrosis, and calcifications."
},
{
"from": "human",
"value": "What are the hormone receptor and HER2 status of the cancer?"
},
{
"from": "gpt",
"value": "The cancer is estrogen receptor (ER) positive at 80%, progesterone receptor (PR) positive at 70%, and HER2-positive at 3+."
},
{
"from": "human",
"value": "What is the purpose of a stereotactic biopsy in the context of breast cancer evaluation?"
},
{
"from": "gpt",
"value": "A stereotactic biopsy is a procedure used to obtain a tissue sample from a specific area of the breast, typically when a mammogram or ultrasound shows suspicious calcifications or a mass. In this case, it was recommended to evaluate fine pleomorphic calcifications in the left breast."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "When was the patient's anesthesia started and stopped?"
},
{
"from": "gpt",
"value": "The patient's anesthesia was started at 1054 and stopped at 1611 on January 8, 2025."
},
{
"from": "human",
"value": "What is the date of the patient's admission to the hospital?"
},
{
"from": "gpt",
"value": "The patient was admitted to the hospital on January 8, 2025."
},
{
"from": "human",
"value": "What is the patient's diagnosis?"
},
{
"from": "gpt",
"value": "The patient has bilateral nipple sparing mastectomy with left invasive ductal carcinoma of breast, female, left sentinel lymph node biopsy (bilateral) and left axillary sentinel lymph node biopsy (left)."
},
{
"from": "human",
"value": "What medication was administered to the patient on January 8, 2025 at 1130?"
},
{
"from": "gpt",
"value": "The patient received 1,000 mg of acetaminophen IV."
},
{
"from": "human",
"value": "Who was the responsible provider for the patient's care?"
},
{
"from": "gpt",
"value": "The responsible provider for the patient's care was Dr. Vibhuti Chopra."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's ER and PR status?"
},
{
"from": "gpt",
"value": "The patient's ER status is 80% and their PR status is 70%."
},
{
"from": "human",
"value": "What was the result of the stereotactic biopsy performed on 05/20/2024?"
},
{
"from": "gpt",
"value": "The stereotactic biopsy performed on 05/20/2024 revealed invasive poorly differentiated ductal carcinoma measuring 7 mm in greatest length, as well as ductal carcinoma in situ (DCIS) with high nuclear grade, solid type, and necrosis and calcifications."
},
{
"from": "human",
"value": "What is the patient's Her2 status?"
},
{
"from": "gpt",
"value": "The patient's Her2 status is 3+, indicating that they are Her2-positive."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the patient's age and menopausal status?"
},
{
"from": "gpt",
"value": "The patient is 41 years old and premenopausal."
},
{
"from": "human",
"value": "What is the patient's current medication regimen?"
},
{
"from": "gpt",
"value": "The patient is currently taking buspirone 5mg tablets and dexamethasone 4mg tablets, which she takes 2 times a day for 2 doses the day before chemotherapy and then 2 times a day for 3 doses starting the evening after."
},
{
"from": "human",
"value": "What are the patient's concerns and preferences regarding treatment?"
},
{
"from": "gpt",
"value": "The patient is tentatively interested in a bilateral possible nipple-sparing mastectomy with left-sided sentinel lymph node biopsy (SLNB) and reconstruction. She is unsure whether to pursue neoadjuvant chemotherapy (NACT) first or surgery first."
},
{
"from": "human",
"value": "What type of genetic testing has the patient undergone, and what were the results?"
},
{
"from": "gpt",
"value": "The patient has undergone genetic testing, which was negative."
},
{
"from": "human",
"value": "What other medical professionals has the patient consulted prior to this visit?"
},
{
"from": "gpt",
"value": "The patient has seen medical oncology, plastic surgery, a second opinion surgical oncology, and a second opinion medical oncology at Memorial Sloan Kettering (MSK) in addition to seeing medical oncology and plastic surgery at New York-Presbyterian (NYP)."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What are some common side effects of medication?"
},
{
"from": "gpt",
"value": "Some common side effects of this medication include drowsiness, dry mouth, and dry eyes."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the ASA (American Society of Anesthesiologists) Physical Status classification for this patient?"
},
{
"from": "gpt",
"value": "The ASA classification for this patient is 2."
},
{
"from": "human",
"value": "What type of anesthesia plan was discussed with the patient/parent/legal guardian/healthcare proxy?"
},
{
"from": "gpt",
"value": "The anesthetic plan, including pain management, available anesthetic options and their individual risks and benefits, were discussed with the patient/parent/legal guardian/healthcare proxy."
},
{
"from": "human",
"value": "What type of pain management plan was used?"
},
{
"from": "gpt",
"value": "A multimodal analgesia plan was used for this patient, starting 6 hours prior to anesthesia start to PACU discharge."
},
{
"from": "human",
"value": "What is the preferred language of the patient?"
},
{
"from": "gpt",
"value": "The preferred language of the patient is English."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the color of the fruit on a Berberis asiatica plant?"
},
{
"from": "gpt",
"value": "The fruit on a Berberis asiatica plant is dark purple, and is oblong-ovoid in shape."
},
{
"from": "human",
"value": "What is the typical shape of the leaves on a Berberis asiatica plant?"
},
{
"from": "gpt",
"value": "The leaves on a Berberis asiatica plant are typically elliptic to ovate-oblong, with spiny margins."
},
{
"from": "human",
"value": "What is a potential issue with eating too much of the fruit from a Berberis asiatica plant?"
},
{
"from": "gpt",
"value": "If excessively eaten, the fruit from a Berberis asiatica plant can upset the stomach."
},
{
"from": "human",
"value": "What is the typical color of the stem and shoots on a Berberis chitria plant?"
},
{
"from": "gpt",
"value": "The stem and shoots on a Berberis chitria plant are typically dark reddish-brown, and are spiny."
},
{
"from": "human",
"value": "What is the typical shape of the berries on a Berberis chitria plant?"
},
{
"from": "gpt",
"value": "The berries on a Berberis chitria plant are typically dark red-brown, and are narrowly ovoid or oblong-ellipsoid in shape."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's lymph node status, as recorded during the physical exam?"
},
{
"from": "gpt",
"value": "There is no axillary, supraclavicular, or infraclavicular adenopathy."
},
{
"from": "human",
"value": "What is the patient's general appearance, as described during the physical exam?"
},
{
"from": "gpt",
"value": "The patient is described as well-nourished and well-conformed."
},
{
"from": "human",
"value": "What is the patient's blood pressure, as recorded during the physical exam?"
},
{
"from": "gpt",
"value": "The patient's blood pressure is 122/72."
},
{
"from": "human",
"value": "What is the patient's height and weight, as recorded during the physical exam?"
},
{
"from": "gpt",
"value": "The patient is 1.6 meters (5' 3\") tall and weighs 66.2 kilograms (146 pounds)."
},
{
"from": "human",
"value": "What is the patient's breast exam result, as recorded during the physical exam?"
},
{
"from": "gpt",
"value": "The patient's breasts are symmetrical with normal contour, with no skin edema, erythema, or dimpling. The nipples and areolar complex are normal, with no retraction or evidence of nipple discharge. There are no dominant masses or other palpable abnormalities."
},
{
"from": "human",
"value": "What is the patient's neurological status, as recorded during the physical exam?"
},
{
"from": "gpt",
"value": "The patient is alert and oriented x 3, with no gross motor-sensory deficits."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the approximate distance between the 2 clips and residual calcifications anteriorly in the breast?"
},
{
"from": "gpt",
"value": "The 2 clips and residual calcifications are approximately 6 cm apart."
},
{
"from": "human",
"value": "What is the largest focus of invasive carcinoma found in the material, and what is its size?"
},
{
"from": "gpt",
"value": "The largest focus of invasive carcinoma spans at least 1.5 mm in the material."
},
{
"from": "human",
"value": "What type of carcinoma is present in the breast tissue, and what is its grade?"
},
{
"from": "gpt",
"value": "The breast tissue contains invasive ductal carcinoma and ductal carcinoma in situ (DCIS), with the DCIS being of a solid type and high nuclear grade."
},
{
"from": "human",
"value": "What are the hormone receptor statuses of the carcinoma, and what is the HER2 status?"
},
{
"from": "gpt",
"value": "The carcinoma is ER-positive (80%), PR-positive (70%), and HER2-positive (3+)."
},
{
"from": "human",
"value": "What is the clinical and pathological stage of the cancer?"
},
{
"from": "gpt",
"value": "The cancer is classified as invasive poorly differentiated ductal carcinoma (clinical T2-3N0), with a path prognostic stage of IA/IB."
},
{
"from": "human",
"value": "What is the result of the 34-gene panel test?"
},
{
"from": "gpt",
"value": "The 34-gene panel test is negative."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the status of the medication package 99999-501-09?"
},
{
"from": "gpt",
"value": "The medication package 99999-501-09 has been discontinued."
},
{
"from": "human",
"value": "What is the time period during which the medication package 99999-501-09 was ordered?"
},
{
"from": "gpt",
"value": "The medication package 99999-501-09 was ordered from 09/12/25 0758 to 09/12/25 0915."
},
{
"from": "human",
"value": "What is the indication of use for the medication package 99999-501-09?"
},
{
"from": "gpt",
"value": "The indication of use for the medication package 99999-501-09 is local anesthesia."
},
{
"from": "human",
"value": "Who authorized the ordering of the medication package 99999-501-09?"
},
{
"from": "gpt",
"value": "The medication package 99999-501-09 was authorized by Chang, Jerry W, MD."
},
{
"from": "human",
"value": "What is the ordering mode for the medication package 99999-501-09?"
},
{
"from": "gpt",
"value": "The ordering mode for the medication package 99999-501-09 is per protocol, with no cosign required."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What was done to the acellular dermal matrix in the left breast area?"
},
{
"from": "gpt",
"value": "The excess acellular dermal matrix was trimmed at the level of the anterior axillary line, and then tacked down to the chest wall at the same level using 3-0 Polysorb suture in an interrupted fashion."
},
{
"from": "human",
"value": "What type of suture was used to close the skin edges of the left breast?"
},
{
"from": "gpt",
"value": "3-0 barbed suture was used in a running subcuticular stitch to close the skin edges of the left breast."
},
{
"from": "human",
"value": "Were there any complications during the plastic surgery portion of the procedure?"
},
{
"from": "gpt",
"value": "No, the patient tolerated the plastic surgery portion of the procedure well, and there were no complications during this portion of the procedure."
},
{
"from": "human",
"value": "How many Jackson-Pratt drains were placed in the left breast, and where were they brought out through the skin?"
},
{
"from": "gpt",
"value": "Two flat Jackson-Pratt drains were placed in the left breast, one (#7) was brought out inferiorly, and the other (#10) was brought out superiorly into the axillary region, both through the skin in the lateral inframammary fold area."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What was the recommendation for the patient's care?"
},
{
"from": "gpt",
"value": "The recommendation was for MRI-guided biopsy of the posterior extent of the enhancement to document the extent of the disease, unless mastectomy is planned."
},
{
"from": "human",
"value": "Were there any findings on the patient's right breast?"
},
{
"from": "gpt",
"value": "Yes, there were a couple of probably benign findings on the right breast."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the medication being used to treat?"
},
{
"from": "gpt",
"value": "The medication is being used to treat an infusion-related reaction, as part of a treatment plan for a patient with malignant neoplasm of overlapping sites of left breast, estrogen receptor positive."
},
{
"from": "human",
"value": "What are the indications for giving this medication?"
},
{
"from": "gpt",
"value": "The medication is given for mucocutaneous symptoms (such as flushing, hives, itching), respiratory symptoms (such as dyspnea, wheezing, bronchospasm, stridor, and oxygen saturation less than 90%), and/or a greater than 30% reduction in blood pressure from baseline caused by an infusion reaction."
},
{
"from": "human",
"value": "What are some common side effects of medication?"
},
{
"from": "gpt",
"value": "Common side effects of this medication include dizziness and headache."
},
{
"from": "human",
"value": "How should this medication be administered?"
},
{
"from": "gpt",
"value": "The medication should be diluted to a maximum concentration of 4 mg/mL and may be administered intravenously (I.V.) at a rate of 10 mg/minute. It is intended to be given as an IV push over a pre-specified duration, and should not be given using an IV piggyback."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the name of the medication that was given to a patient on January 9, 2025, at 19:12?"
},
{
"from": "gpt",
"value": "The medication given was gabapentin, also known as Neurontin."
},
{
"from": "human",
"value": "What is the risk associated with the use of heparin injection?"
},
{
"from": "gpt",
"value": "The risk associated with the use of heparin injection is a high alert for bleeding and bruising."
},
{
"from": "human",
"value": "How often was the heparin injection scheduled to be given?"
},
{
"from": "gpt",
"value": "The heparin injection was scheduled to be given every 8 hours."
},
{
"from": "human",
"value": "What is the indication for the use of heparin injection?"
},
{
"from": "gpt",
"value": "The indication for the use of heparin injection is DVT (Deep Vein Thrombosis) prophylaxis."
},
{
"from": "human",
"value": "Where was the heparin injection administered on January 9, 2025, at 14:12?"
},
{
"from": "gpt",
"value": "The heparin injection was administered subcutaneously in the right upper arm (back)."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is unique about the flowering behavior of Sihi Myak?"
},
{
"from": "gpt",
"value": "Sihi Myak flowers only once in 12 years and dies after flowering."
},
{
"from": "human",
"value": "What are some of the uses of bamboo culms in the local landscape?"
},
{
"from": "gpt",
"value": "Locally termed \"Myak\", bamboo culms have multiple uses, including re-doing fencing and making new \"dokos\" (traditional structures)."
},
{
"from": "human",
"value": "How long does it take for Sihi Myak to regenerate again after flowering?"
},
{
"from": "gpt",
"value": "It takes about 8-9 years for Sihi Myak to regenerate again after flowering."
},
{
"from": "human",
"value": "What are the names of the 5 ethno species of bamboo recognized by the Gurung ethnic community?"
},
{
"from": "gpt",
"value": "The 5 ethno species of bamboo recognized by the Gurung ethnic community are: Mwang, Sir Myak, Pan Myak, Kha Myak, and Sihi Myak."
},
{
"from": "human",
"value": "How many ethno species of bamboo are recognized by the Gurung ethnic community?"
},
{
"from": "gpt",
"value": "The Gurung ethnic community recognizes 5 ethno species of bamboo based on ecological zone."
},
{
"from": "human",
"value": "What is the ranking of bamboo species?"
},
{
"from": "gpt",
"value": "The people of the MCA rank bamboo species as the most used and most useful plant species in their landscape."
},
{
"from": "human",
"value": "Which ethno species of bamboo is considered to be of the best quality?"
},
{
"from": "gpt",
"value": "Sihi Myak is considered to be of the best quality."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the reported state of a person's behavior?"
},
{
"from": "gpt",
"value": "The reported state of a person's behavior is normal."
},
{
"from": "human",
"value": "What is the reported state of a person's mood according to the available information?"
},
{
"from": "gpt",
"value": "The reported state of a person's mood is normal."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the normal range for sodium levels in the blood?"
},
{
"from": "gpt",
"value": "The normal range for sodium levels in the blood is between 136 and 145 mmol/L."
},
{
"from": "human",
"value": "What is the level of potassium in the blood for this patient?"
},
{
"from": "gpt",
"value": "The level of potassium in the blood for this patient is 3.9 mmol/L."
},
{
"from": "human",
"value": "What is the normal range for chloride levels in the blood?"
},
{
"from": "gpt",
"value": "The normal range for chloride levels in the blood is between 98 and 107 mmol/L."
},
{
"from": "human",
"value": "What is the level of carbon dioxide in the blood for this patient?"
},
{
"from": "gpt",
"value": "The level of carbon dioxide in the blood for this patient is 22 mmol/L."
},
{
"from": "human",
"value": "What is the level of creatinine in the blood for this patient?"
},
{
"from": "gpt",
"value": "The level of creatinine in the blood for this patient is 0.69 mg/dL."
},
{
"from": "human",
"value": "What is the normal range for blood urea nitrogen (BUN) levels in the blood?"
},
{
"from": "gpt",
"value": "The normal range for BUN levels in the blood is between 6.0 and 20.0 mg/dL."
},
{
"from": "human",
"value": "What is the normal range for glucose levels in the blood?"
},
{
"from": "gpt",
"value": "The normal range for glucose levels in the blood is between 74 and 106 mg/dL."
},
{
"from": "human",
"value": "What is the level of total calcium in the blood for this patient?"
},
{
"from": "gpt",
"value": "The level of total calcium in the blood for this patient is 9.4 mg/dL."
},
{
"from": "human",
"value": "What is the normal range for the anion gap?"
},
{
"from": "gpt",
"value": "The normal range for the anion gap is between 5 and 17."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the clinical indication for the imaging study described?"
},
{
"from": "gpt",
"value": "The clinical indication is to evaluate for a sonographic correlate of left breast invasive cancer that was recently diagnosed on an outside stereotactic biopsy in May 2024."
},
{
"from": "human",
"value": "What is the impression of the ultrasound findings for the right breast?"
},
{
"from": "gpt",
"value": "The impression is that there are a couple of probably benign findings on the right breast, including a 4 mm hypoechoic probable complicated cyst cluster and a slightly hypoechoic nodular area that is probably benign."
},
{
"from": "human",
"value": "What is the impression of the ultrasound findings for the left breast?"
},
{
"from": "gpt",
"value": "The impression is that there is a suspicious lesion at the 6:00 position, corresponding to the previously biopsied region, and a 28 mm irregular hypoechoic mass with an adjacent biopsy clip suggested."
},
{
"from": "human",
"value": "What is the BIRADS classification for the left breast lesion?"
},
{
"from": "gpt",
"value": "The BIRADS classification is 6, which is known to be biopsy-proven malignancy (ultrasound only)."
},
{
"from": "human",
"value": "What is the recommended course of action for the left breast lesion?"
},
{
"from": "gpt",
"value": "The recommended course of action is surgical biopsy/treatment of known malignancy."
},
{
"from": "human",
"value": "What is the recommended follow-up for the right breast sonographic findings?"
},
{
"from": "gpt",
"value": "The recommended follow-up is 6-month follow-up for the right sonographic findings noted above."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the size of the aortic root, and at what level was it measured?"
},
{
"from": "gpt",
"value": "The aortic root is normal size at the level of the sinuses of Valsalva."
},
{
"from": "human",
"value": "Can you list the valves that were found to be normal in structure and function?"
},
{
"from": "gpt",
"value": "The following valves were found to be normal in structure and function:\n\n* Aortic Valve\n* Mitral Valve\n* Tricuspid Valve\n* Pulmonic Valve"
},
{
"from": "human",
"value": "What is the size of the left ventricle, and what is its function?"
},
{
"from": "gpt",
"value": "The left ventricle is normal in size, and its function is normal. Specifically, left ventricular systolic function is normal, and the left ventricular wall motion is normal."
},
{
"from": "human",
"value": "What is the size of the inferior vena cava, and what does this indicate about the right atrial pressure?"
},
{
"from": "gpt",
"value": "The inferior vena cava is less than 2.1 cm and exhibits reduced respiratory variability, which is consistent with a right atrial pressure of approximately 8 mm Hg."
},
{
"from": "human",
"value": "What is the estimated ejection fraction of the left ventricle, based on Simpson's method?"
},
{
"from": "gpt",
"value": "The estimated ejection fraction of the left ventricle is 65.6%."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the dosage of the medication being administered?"
},
{
"from": "gpt",
"value": "The dosage of the medication being administered is 25 mg."
},
{
"from": "human",
"value": "What is the timing of the medication administration?"
},
{
"from": "gpt",
"value": "The medication is to be given 30 minutes prior to chemotherapy."
},
{
"from": "human",
"value": "What is the package identifier for the medication being administered?"
},
{
"from": "gpt",
"value": "The package identifier for the medication being administered is 47426-201-01."
},
{
"from": "human",
"value": "What is the name of the medication being administered, and what is its purpose?"
},
{
"from": "gpt",
"value": "The medication being administered is diphenhydrAMINE (BENADRYL) injection, and its purpose is to act as a premedication before chemotherapy."
},
{
"from": "human",
"value": "What are some common side effects of the medication being administered?"
},
{
"from": "gpt",
"value": "Some common side effects of the medication being administered include fatigue, diarrhea, slow heart rate, drowsiness, dry mouth, and dry eyes."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "Who is authorized to act on this order?"
},
{
"from": "gpt",
"value": "The ordering provider, Dekyi, Tenzin, NP, is authorized to act on this order."
},
{
"from": "human",
"value": "What is the indication for performing IV line clearance?"
},
{
"from": "gpt",
"value": "IV line clearance should be performed when a low volume infusion (250 mL or less) is needed."
},
{
"from": "human",
"value": "What solution is used for IV line clearance for low volume infusions (250 mL or less)?"
},
{
"from": "gpt",
"value": "For low volume infusions (250 mL or less), 20 mL of a compatible solution, specifically dextrose 5% or sodium chloride 0.9%, is used for IV line clearance."
},
{
"from": "human",
"value": "When was this order discontinued?"
},
{
"from": "gpt",
"value": "This order was discontinued on October 10, 2024, at 1209 by Oh, Jane, RN."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's diagnosis, and what procedure was performed?"
},
{
"from": "gpt",
"value": "The patient's diagnosis is bilateral reconstructed breast, with a personal history of malignant neoplasm of the breast. The procedure performed was revision and fat grafting."
},
{
"from": "human",
"value": "What type of anesthesia was used during the procedure, and what was the patient's ASA status?"
},
{
"from": "gpt",
"value": "The type of anesthesia used was general anesthesia, and the patient's ASA status was 2."
},
{
"from": "human",
"value": "Who were the surgeons and responsible provider involved in the patient's care?"
},
{
"from": "gpt",
"value": "The surgeons involved were Jerry W Chang, MD, and the responsible provider was Vibhuti Chopra, MD."
},
{
"from": "human",
"value": "What is the date of the patient's admission and discharge?"
},
{
"from": "gpt",
"value": "The patient was admitted and discharged on September 12, 2025."
},
{
"from": "human",
"value": "What were the patient's vital signs during the procedure, and were there any complications?"
},
{
"from": "gpt",
"value": "The patient's vital signs during the procedure were:\n\n* Blood pressure: 118/76\n* Temperature: 36.6 °C\n* Pulse: 73\n* Respiratory rate: 16\n* Oxygen saturation: 98%\n\nThere were no anesthetic complications reported."
},
{
"from": "human",
"value": "What was the outcome of the post-anesthesia evaluation?"
},
{
"from": "gpt",
"value": "The patient's pain was adequately controlled, and there were no anesthetic complications or cardiovascular, respiratory, or hydration issues reported."
},
{
"from": "human",
"value": "What was the patient's level of consciousness and hydration status during the post-anesthesia evaluation?"
},
{
"from": "gpt",
"value": "The patient was awake and alert during the post-anesthesia evaluation, and their hydration status was adequate."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the result of the Hepatitis B Core Antibody test?"
},
{
"from": "gpt",
"value": "The result of the Hepatitis B Core Antibody test is Non-Reactive."
},
{
"from": "human",
"value": "What is the significance of a Non-Reactive result for the Hepatitis B Core Antibody test?"
},
{
"from": "gpt",
"value": "A Non-Reactive result for the Hepatitis B Core Antibody test indicates that the patient does not have antibodies to the hepatitis B virus or that the antibodies are below the detection limit of the test. However, it does not exclude the possibility of exposure to the virus."
},
{
"from": "human",
"value": "What are some limitations of the Elecsys Anti-HBc II assay used to detect Hepatitis B Core Antibody?"
},
{
"from": "gpt",
"value": "The Elecsys Anti-HBc II assay may produce false positive results due to non-specific reactivity, and false negative results may occur if the patient's antibodies are below the detection limit of the assay or if the patient's antibodies do not react with the antigen used in the test."
},
{
"from": "human",
"value": "What is the difference between a reactive and a non-reactive result for the Hepatitis B Core Antibody test?"
},
{
"from": "gpt",
"value": "A reactive result for the Hepatitis B Core Antibody test indicates that the patient has antibodies to the hepatitis B virus, which may indicate a present or past infection. A non-reactive result, on the other hand, indicates that the patient does not have antibodies to the virus or that the antibodies are below the detection limit of the test."
},
{
"from": "human",
"value": "What is the importance of considering the patient's medical history, clinical examination, and other findings when interpreting the results of the Hepatitis B Core Antibody test?"
},
{
"from": "gpt",
"value": "The results of the Hepatitis B Core Antibody test should always be assessed in conjunction with the patient's medical history, clinical examination, and other findings to ensure accurate interpretation of the results."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the warning regarding the administration of \"trastuzumab-anns (KANJINTI)\"?"
},
{
"from": "gpt",
"value": "The medication \"trastuzumab-anns (KANJINTI)\" is not compatible with D5W."
},
{
"from": "human",
"value": "What is the indication for the medication \"trastuzumab-anns (KANJINTI)\"?"
},
{
"from": "gpt",
"value": "The indication for the medication \"trastuzumab-anns (KANJINTI)\" is cancer therapy, specifically for a malignant neoplasm of overlapping sites of left breast in a female, estrogen receptor positive."
},
{
"from": "human",
"value": "Who authorized the treatment plan \"TCHP Neoadjuvant\"?"
},
{
"from": "gpt",
"value": "The treatment plan \"TCHP Neoadjuvant\" was authorized by Murthy, Pooja, MD."
},
{
"from": "human",
"value": "Who is responsible for discontinuing the medication \"trastuzumab-anns (KANJINTI)\"?"
},
{
"from": "gpt",
"value": "The medication \"trastuzumab-anns (KANJINTI)\" was discontinued by Pagsuguiron, Maria Jovie, NP on 10/31/24 1225."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "Who authorized the treatment?"
},
{
"from": "gpt",
"value": "The treatment was authorized by Dekyi, Tenzin, NP."
},
{
"from": "human",
"value": "What is the status of the treatment?"
},
{
"from": "gpt",
"value": "The treatment has been discontinued."
},
{
"from": "human",
"value": "What is the recommended procedure for low-volume infusions (250 mL or less)?"
},
{
"from": "gpt",
"value": "The recommended procedure for low-volume infusions (250 mL or less) is to perform IV line clearance with 20 mL of a compatible solution."
},
{
"from": "human",
"value": "What is the name of the healthcare provider who signed off on the treatment?"
},
{
"from": "gpt",
"value": "The treatment was electronically signed by Dekyi, Tenzin, NP."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What type of enhancement is surrounding the biopsy marker, and what are its dimensions?"
},
{
"from": "gpt",
"value": "The enhancement is described as \"segmental non mass enhancement\" that spans 7.1 cm AP by 2.6 cm craniocaudal by 3.3 cm transversely."
},
{
"from": "human",
"value": "Are there any enlarged lymph nodes in the left axillary or internal mammary regions?"
},
{
"from": "gpt",
"value": "No, there are no enlarged left axillary or internal mammary lymph nodes."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the current condition of the patient's heart valves?"
},
{
"from": "gpt",
"value": "The patient's aortic valve, mitral valve, and tricuspid valve are all normal in structure and function."
},
{
"from": "human",
"value": "Was the patient's Pulmonary Artery Systolic Pressure (PASP) able to be assessed?"
},
{
"from": "gpt",
"value": "No, the patient's PASP could not be assessed."
},
{
"from": "human",
"value": "What is the patient's current blood pressure?"
},
{
"from": "gpt",
"value": "The patient's blood pressure is 107/78."
},
{
"from": "human",
"value": "Is the patient's airway normal?"
},
{
"from": "gpt",
"value": "Yes, the patient's airway is normal, with a Mallampati score of II, full neck range of motion, normal mouth opening, and the ability to protrude the lower jaw."
},
{
"from": "human",
"value": "What is the patient's current height and weight?"
},
{
"from": "gpt",
"value": "The patient's height is 162.6 cm and their weight is 60.3 kg."
},
{
"from": "human",
"value": "Was the patient able to eat or drink anything before the examination?"
},
{
"from": "gpt",
"value": "No, the patient was on a NPO (nil per os) status, meaning they had not eaten or drunk anything since 9/11/25 at 2230."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What was the initial information that led the author to decide to work at the MCA?"
},
{
"from": "gpt",
"value": "The initial information that led the author to decide to work at the MCA was a brochure published by the Department of National Parks and Wildlife Conservation in Kathmandu. The brochure mentioned MCA as one of the youngest conservation areas in Nepal, and it was located around Mount Manaslu, the eighth highest mountain in the world."
},
{
"from": "human",
"value": "What was the state of ethnobotanical research in the MCA region before the author's work?"
},
{
"from": "gpt",
"value": "Very little ethnobotanical work had been conducted in the MCA region before the author's work, and even less research had been done during or after the civil war led by Maoists in the district of Gorkha where MCA is situated."
},
{
"from": "human",
"value": "Why did the author decide to conduct a baseline flora survey in the MCA region?"
},
{
"from": "gpt",
"value": "The author decided to conduct a baseline flora survey in the MCA region in order to document the local knowledge on forests and resources before they become modified or disappear altogether. The author wanted to understand the landscape through the perception of the local residents and to learn more about the bioculture of the area."
},
{
"from": "human",
"value": "What are some of the changes that the MCA region is experiencing due to the end of the civil war?"
},
{
"from": "gpt",
"value": "The end of the civil war has led to the initiation of developmental projects such as road building, hydroelectric power, and large-scale tourism projects in the MCA region. As a result, tourists and trekkers are beginning to visit the area, which is causing changes to the landscape and potentially threatening the local environment."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the patient's diagnosis?"
},
{
"from": "gpt",
"value": "The patient has a malignant neoplasm of overlapping sites of the left breast, which is estrogen receptor positive."
},
{
"from": "human",
"value": "What is the purpose of administering sodium chloride 0.9% to the patient?"
},
{
"from": "gpt",
"value": "Sodium chloride 0.9% is being administered as a flush to clear the IV line, and also as a component of the medication mixture."
},
{
"from": "human",
"value": "What is the purpose of performing IV line clearance with 20 mL of compatible solution?"
},
{
"from": "gpt",
"value": "IV line clearance is being performed to clear the IV line, specifically when administering low-volume infusions (250 mL or less) to prevent any potential issues."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the date of admission and discharge for the patient, according to the information provided?"
},
{
"from": "gpt",
"value": "The date of admission and discharge for the patient is May 28, 2025."
},
{
"from": "human",
"value": "What type of medications can the patient take as needed (PRN)?"
},
{
"from": "gpt",
"value": "The patient can take PRN medications as needed."
},
{
"from": "human",
"value": "Who printed the report?"
},
{
"from": "gpt",
"value": "The report was printed by ZMQ9005."
},
{
"from": "human",
"value": "Are there any facility-administered medications that the patient is currently taking?"
},
{
"from": "gpt",
"value": "No, there are no facility-administered medications for this encounter."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What type of medical procedure is listed in the past surgical history?"
},
{
"from": "gpt",
"value": "A breast biopsy is listed in the left past surgical history."
},
{
"from": "human",
"value": "Which side of the body did the breast biopsy occur on?"
},
{
"from": "gpt",
"value": "The breast biopsy occurred on the left side of the body."
},
{
"from": "human",
"value": "When did the breast biopsy take place?"
},
{
"from": "gpt",
"value": "The breast biopsy took place on June 26, 2024."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What was the result of the genetic testing?"
},
{
"from": "gpt",
"value": "The genetic testing done through Ambry in 2024 was negative for pathogenic mutations."
},
{
"from": "human",
"value": "What symptoms did the patient experience before the biopsies were performed?"
},
{
"from": "gpt",
"value": "The patient did not have any pain, mass, or abnormal nipple discharge before the biopsies."
},
{
"from": "human",
"value": "What treatment did the patient start on August 6, 2024?"
},
{
"from": "gpt",
"value": "The patient began neoadjuvant TCHP (a chemotherapy regimen) on August 6, 2024."
},
{
"from": "human",
"value": "Why was the patient's treatment regimen changed starting with cycle 2?"
},
{
"from": "gpt",
"value": "The patient's treatment regimen was changed due to multiple toxicities, including grade 1-2 neuropathy, which led to the substitution of THP for TCHP."
},
{
"from": "human",
"value": "What substitution was made in the patient's treatment regimen starting with cycle 5?"
},
{
"from": "gpt",
"value": "Starting with cycle 5, Abraxane was substituted for docetaxel due to worsened neuropathy."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the purpose of the medication that was administered, and when should it be given?"
},
{
"from": "gpt",
"value": "The medication was administered as a premedication 60 minutes prior to chemotherapy."
},
{
"from": "human",
"value": "What is the name of the medication that was administered, and what is its dosage?"
},
{
"from": "gpt",
"value": "The medication that was administered is diphenhydrAMINE (BENADRYL), and its dosage is 25 mg."
},
{
"from": "human",
"value": "Who authorized the administration of this medication?"
},
{
"from": "gpt",
"value": "The medication was authorized by Dekyi, Tenzin, NP."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What was the date of the patient's office visit?"
},
{
"from": "gpt",
"value": "The patient's office visit took place on November 21, 2024."
},
{
"from": "human",
"value": "How long did the medical encounter last?"
},
{
"from": "gpt",
"value": "The medical encounter lasted 30 minutes, not including any procedures. This time included preparing to see the patient, reviewing tests, obtaining a medical history, performing a medically appropriate examination, counseling and educating the patient, ordering medications, tests, or procedures, referring and communicating with other healthcare professionals, documenting clinical information in the EMR, independently interpreting results and communicating results to the patient/family/caregiver, and care communication."
},
{
"from": "human",
"value": "What type of appointment was requested for the patient?"
},
{
"from": "gpt",
"value": "The patient was requested to have a chemotherapy infusion appointment."
},
{
"from": "human",
"value": "What is the patient's diagnosis?"
},
{
"from": "gpt",
"value": "The patient has a malignant neoplasm of overlapping sites of the left breast in a female, estrogen receptor positive."
},
{
"from": "human",
"value": "What medications were administered to the patient during the office visit?"
},
{
"from": "gpt",
"value": "The patient received the following medications during the office visit:\n\n* Sodium chloride 0.9% bolus 500 mL\n* EPINEPHrine (ADRENALIN) 1 MG/ML injection 0.3 mL\n* DiphenhydrAMINE (BENADRYL) injection 25 mg (twice)\n* Famotidine (PEPCID) injection 20 mg\n* MethylPREDNISolone sod suc (SOLU-Medrol) injection 125 mg\n* Acetaminophen (TYLENOL) tablet 650 mg\n* Pertuzumab (PERJETA) 420 mg in sodium chloride 0.9% 264 mL\n* Trastuzumab-anns (KANJINTI) 400 mg in sodium chloride 0.9% 269.05 mL"
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the treatment plan for this patient?"
},
{
"from": "gpt",
"value": "The treatment plan is for the patient to undergo chemotherapy infusion as part of the TCHP Neoadjuvant plan."
},
{
"from": "human",
"value": "What is the ordering mode for this treatment plan?"
},
{
"from": "gpt",
"value": "The ordering mode is Standard."
},
{
"from": "human",
"value": "What is the purpose of the chemotherapy infusion appointment?"
},
{
"from": "gpt",
"value": "The purpose of the chemotherapy infusion appointment is Routine, as part of the treatment plan."
},
{
"from": "human",
"value": "What is the quantity of the chemotherapy infusion appointment?"
},
{
"from": "gpt",
"value": "The quantity is 1."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the diagnosis for which the patient is receiving treatment?"
},
{
"from": "gpt",
"value": "The patient is being treated for cancer of the breast, specifically intraductal cancer of unspecified laterality."
},
{
"from": "human",
"value": "Who authorized the ordering of the medication, and when?"
},
{
"from": "gpt",
"value": "The medication was authorized by Murthy, Pooja, MD, on 07/13/24 at 22:06."
},
{
"from": "human",
"value": "Has the patient received education on the treatment and given informed consent?"
},
{
"from": "gpt",
"value": "Yes, the patient has received education on the treatment and has given informed consent."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What type of fluid is being drained from the patient?"
},
{
"from": "gpt",
"value": "The fluid being drained is described as \"dark red\" and is being suctioned using a bulb."
},
{
"from": "human",
"value": "How many milliliters of fluid were drained from the patient on January 8, 2025, at 1443?"
},
{
"from": "gpt",
"value": "25 mL of fluid were drained from the patient on January 8, 2025, at 1443."
},
{
"from": "human",
"value": "What is the concentration of propofol being administered to the patient?"
},
{
"from": "gpt",
"value": "The concentration of propofol being administered to the patient is 10 mg/mL."
},
{
"from": "human",
"value": "Was the hand hygiene completed by the healthcare provider who placed the urethral catheter?"
},
{
"from": "gpt",
"value": "Yes, the hand hygiene was completed by the healthcare provider who placed the urethral catheter."
},
{
"from": "human",
"value": "What is the size of the urethral catheter that was placed in the patient?"
},
{
"from": "gpt",
"value": "The urethral catheter that was placed in the patient has a tube size of 16 Fr."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the maximum velocity of the aortic valve?"
},
{
"from": "gpt",
"value": "The maximum velocity of the aortic valve is 99.9 cm/s."
},
{
"from": "human",
"value": "What is the maximum left ventricular pressure, as measured by Xcelera, in mmHg?"
},
{
"from": "gpt",
"value": "The maximum left ventricular pressure is 2 mmHg."
},
{
"from": "human",
"value": "What is the dimension of the left ventricular posterior wall, as measured by Xcelera, at a certain point?"
},
{
"from": "gpt",
"value": "The dimension of the left ventricular posterior wall is 8 cm."
},
{
"from": "human",
"value": "What is the aortic valve area index?"
},
{
"from": "gpt",
"value": "The aortic valve area index is 1.1."
},
{
"from": "human",
"value": "What is the mean pressure across the aortic valve, as measured by Xcelera, in mmHg?"
},
{
"from": "gpt",
"value": "The mean pressure across the aortic valve is 2.1 mmHg."
},
{
"from": "human",
"value": "What is the mitral valve deceleration time, as measured by Xcelera, in seconds?"
},
{
"from": "gpt",
"value": "The mitral valve deceleration time is 0.2 seconds."
},
{
"from": "human",
"value": "What is the aortic valve velocity ratio?"
},
{
"from": "gpt",
"value": "The aortic valve velocity ratio is 0.7."
},
{
"from": "human",
"value": "What is the lateral annular E' wave velocity, as measured by Xcelera, in cm/s?"
},
{
"from": "gpt",
"value": "The lateral annular E' wave velocity is 14.2 cm/s."
},
{
"from": "human",
"value": "What is the aortic valve velocity time integral, as measured by Xcelera, in cm?"
},
{
"from": "gpt",
"value": "The aortic valve velocity time integral is 22.1 cm."
},
{
"from": "human",
"value": "What is the lateral annular A' wave velocity, as measured by Xcelera, in cm/s?"
},
{
"from": "gpt",
"value": "The lateral annular A' wave velocity is 9.2 cm/s."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "Who helped the author with the production of the book?"
},
{
"from": "gpt",
"value": "Mrs. Tricia Pearsall helped the author with the production of the book, including editing."
},
{
"from": "human",
"value": "What was the author's initial impression of the Manaslu Conservation Area (MCA) when they chose it as the field site for their Ph.D. work?"
},
{
"from": "gpt",
"value": "The author had no idea of the MCA's geographical remoteness and isolation, and they also had no prior knowledge of its people, biological and cultural richness."
},
{
"from": "human",
"value": "What was the author's experience like when traveling to the MCA?"
},
{
"from": "gpt",
"value": "The author's experience involved traveling for 14 hours by bus and in the back of a pickup truck, 8 hours on slick mud roads, and 4 days on foot walking 7-9 hours each day through the Bhudi Gandaki River gorge."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What type of cannula is used for harvesting fat?"
},
{
"from": "gpt",
"value": "The cannula used for harvesting fat is 4 mm tipped."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's height and weight, as recorded on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's height is 157.5 cm and their weight is 60.782 kg."
},
{
"from": "human",
"value": "What is the date of the patient's admission and discharge?"
},
{
"from": "gpt",
"value": "The patient was admitted and discharged on May 28, 2025."
},
{
"from": "human",
"value": "What is the patient's systolic and diastolic blood pressure, as recorded on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's systolic blood pressure is 111 mmHg and their diastolic blood pressure is 73 mmHg."
},
{
"from": "human",
"value": "What is the result of the patient's LV EJECTION FRACTION (%) test on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's LV EJECTION FRACTION (%) result on May 12, 2025 was 67.2%."
},
{
"from": "human",
"value": "What is the patient's left atrial dimension, as measured on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's left atrial dimension is 2.6 cm."
},
{
"from": "human",
"value": "What is the patient's inferior vena cava diameter, as measured on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's inferior vena cava diameter is 2 cm."
},
{
"from": "human",
"value": "What is the patient's Body Mass Index (BMI), as calculated on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's BMI is 24.5."
},
{
"from": "human",
"value": "What is the patient's left ventricular area at end diastole, as measured on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's left ventricular area at end diastole is 14.3 cm^2 (apical 2CH)."
},
{
"from": "human",
"value": "What is the patient's left ventricular end-diastolic volume, as measured on May 12, 2025?"
},
{
"from": "gpt",
"value": "The patient's left ventricular end-diastolic volume is 99.8 mL (modified 4CH)."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the purpose of administering the medication, and what are the specific indications for use?"
},
{
"from": "gpt",
"value": "The medication is administered to treat severe respiratory distress (wheezing, bronchospasm, stridor, oxygen saturation <90%) and/or >30% reduction in blood pressure from baseline caused by an infusion reaction. It is also given in combination with other medications for the same indication."
},
{
"from": "human",
"value": "What is the diagnosis for the patient, and what are the estrogen receptor status and ICD codes for this diagnosis?"
},
{
"from": "gpt",
"value": "The diagnosis is a malignant neoplasm of overlapping sites of the left breast in a female, which is estrogen receptor positive. The ICD codes for this diagnosis are C50.812 and Z17.0."
},
{
"from": "human",
"value": "What are the instructions for administering ipratropium and the medication in question, if both are ordered for the same indication?"
},
{
"from": "gpt",
"value": "Both medications should be administered according to their dosing frequency."
},
{
"from": "human",
"value": "Who authorized the ordering of the medication, and what was the mode of ordering?"
},
{
"from": "gpt",
"value": "The medication was authorized by Dr. Murthy, and the ordering mode was standard PRN."
},
{
"from": "human",
"value": "What is the status of the medication, and when was it discontinued?"
},
{
"from": "gpt",
"value": "The medication was discontinued, and it was discontinued by Discharge Provider, Automatic on 01/18/25 at 0434."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is a notable feature of the leaves of some plants?"
},
{
"from": "gpt",
"value": "Some of the plants described in the text have leaves that are oppositely arranged, meaning that they are paired on either side of the stem."
},
{
"from": "human",
"value": "What is a common use of the plants?"
},
{
"from": "gpt",
"value": "A common use of the plants is as fuel wood."
},
{
"from": "human",
"value": "What is a notable feature of the leaves of some plants?"
},
{
"from": "gpt",
"value": "Some of the plants described in the text have leaves that are abaxially stellately pubescent, meaning that they have a stellate (star-shaped) pattern of hairs on the underside of the leaf."
},
{
"from": "human",
"value": "How do the inflorescences of some of the plants appear?"
},
{
"from": "gpt",
"value": "Some of the plants described in the text have inflorescences that appear as compound umbel-like cymes, which are a type of branching flower cluster."
},
{
"from": "human",
"value": "What is a notable feature of the crushed leaves and stems of some plants?"
},
{
"from": "gpt",
"value": "Some of the plants described in the text have crushed leaves and stems that have an unpleasant smell."
},
{
"from": "human",
"value": "What is a notable feature of the inflorescence of some plants?"
},
{
"from": "gpt",
"value": "Some of the plants described in the text have inflorescences that appear as terminal cymes, which are a type of branching flower cluster that occurs at the end of a stem."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the treatment plan being followed for the patient?"
},
{
"from": "gpt",
"value": "The treatment plan involves the administration of Trastuzumab and Pertuzumab, which are used for cancer therapy in an adjuvant setting."
},
{
"from": "human",
"value": "What is the frequency of the treatment, and when is it scheduled to take place?"
},
{
"from": "gpt",
"value": "The treatment is scheduled to take place once, on April 10, 2025, at 1:15 PM."
},
{
"from": "human",
"value": "Are there any special instructions for the administration of the medication?"
},
{
"from": "gpt",
"value": "Yes, the medication is NOT compatible with D5W."
},
{
"from": "human",
"value": "What are the ingredients of the medication being administered, and what is the dose of each ingredient?"
},
{
"from": "gpt",
"value": "The medication being administered is trastuzumab-anns (KANJINTI), which is given at a dose of 6 mg/kg. The medication also contains sodium chloride 0.9% at a dose of 250 mL."
},
{
"from": "human",
"value": "Who authorized the ordering of the medication, and who is responsible for its administration?"
},
{
"from": "gpt",
"value": "The medication was authorized by Dr. Murthy, and it is being administered by a nurse, as indicated by the signature of Edward Pae, RN."
},
{
"from": "human",
"value": "What is the status of the medication order?"
},
{
"from": "gpt",
"value": "The medication order has been completed, as indicated by the status \"Completed\"."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "Where is the acellular dermal matrix tacked down to on the chest wall?"
},
{
"from": "gpt",
"value": "The acellular dermal matrix is tacked down to the chest wall at the level of the inframammary fold, using 3-0 Polysorb sutures in an interrupted fashion."
},
{
"from": "human",
"value": "What is placed in the prepectoral plane, and how is it seated?"
},
{
"from": "gpt",
"value": "A Dermaspan mid height tissue expander is placed in the prepectoral plane, and it is seated as medially and inferiorly as possible."
},
{
"from": "human",
"value": "What type of suture is used to tack down the acellular dermal matrix to the chest wall?"
},
{
"from": "gpt",
"value": "3-0 Polysorb suture is used to tack down the acellular dermal matrix to the chest wall."
},
{
"from": "human",
"value": "How are the tabs of the tissue expander secured?"
},
{
"from": "gpt",
"value": "The tabs of the tissue expander are secured to the pectoralis major muscle using 3-0 Polysorb suture."
},
{
"from": "human",
"value": "What is draped over the tissue expander, and how is it secured?"
},
{
"from": "gpt",
"value": "The acellular dermal matrix is draped over the tissue expander, and the superior edge of the acellular dermal matrix is secured to the pectoralis major muscle cephalad to the superior edge of the tissue expander using 3-0 Polysorb suture in an interrupted fashion."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the date of the patient's admission to the hospital?"
},
{
"from": "gpt",
"value": "The patient was admitted to the hospital on January 8, 2025."
},
{
"from": "human",
"value": "What is the date and time of the patient's discharge from the hospital?"
},
{
"from": "gpt",
"value": "The patient was discharged from the hospital on January 9, 2025 at 2346."
},
{
"from": "human",
"value": "Who electronically signed the discharge order for the patient?"
},
{
"from": "gpt",
"value": "The discharge order was electronically signed by Dr. Kaitlyn Petitpas on January 8, 2025 at 1535."
},
{
"from": "human",
"value": "What is the status of the order for the patient's temperature to be monitored?"
},
{
"from": "gpt",
"value": "The order for the patient's temperature to be monitored has been discontinued."
},
{
"from": "human",
"value": "What is the status of the order for the patient's vital signs to be monitored every 4 hours?"
},
{
"from": "gpt",
"value": "The order for the patient's vital signs to be monitored every 4 hours has been discontinued."
},
{
"from": "human",
"value": "What is the authorized provider for the patient's care?"
},
{
"from": "gpt",
"value": "The authorized provider for the patient's care is Dr. Tammy Ju."
},
{
"from": "human",
"value": "What is the mode in which the order for the patient's care was placed?"
},
{
"from": "gpt",
"value": "The order for the patient's care was placed in the standard mode."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the diagnosis of the patient in question?"
},
{
"from": "gpt",
"value": "The patient has a malignant neoplasm of overlapping sites of the left breast, and is a female with estrogen receptor-positive breast cancer."
},
{
"from": "human",
"value": "What type of treatment is being administered to the patient?"
},
{
"from": "gpt",
"value": "The patient is undergoing chemotherapy."
},
{
"from": "human",
"value": "What is the name of the nurse who auto-released the instance of the treatment?"
},
{
"from": "gpt",
"value": "The instance was released by Oh, Jane, RN."
},
{
"from": "human",
"value": "Who is responsible for ordering the treatment for the patient?"
},
{
"from": "gpt",
"value": "The treatment was ordered by Murthy, Pooja, MD."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the purpose of the Goserelin (ZOLADEX) medication that was administered on August 8, 2024?"
},
{
"from": "gpt",
"value": "The purpose of the Goserelin (ZOLADEX) medication was for chemotherapy for cancer."
},
{
"from": "human",
"value": "Who authorized the administration of the Goserelin (ZOLADEX) medication on August 8, 2024?"
},
{
"from": "gpt",
"value": "The administration of the Goserelin (ZOLADEX) medication was authorized by Dr. Pooja Murthy."
},
{
"from": "human",
"value": "What is the instruction for administering a low volume infusion (250 mL or less)?"
},
{
"from": "gpt",
"value": "The instruction for administering a low volume infusion (250 mL or less) is to perform IV line clearance with 20 mL of compatible solution."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the average pressure gradient (PG) across the left ventricle?"
},
{
"from": "gpt",
"value": "1.5 mmHg."
},
{
"from": "human",
"value": "What is the maximum velocity of blood flow through the left ventricular outflow tract (LVOT)?"
},
{
"from": "gpt",
"value": "83.9 cm/s."
},
{
"from": "human",
"value": "What is the mean velocity of blood flow through the left ventricle?"
},
{
"from": "gpt",
"value": "58.0 cm/s."
},
{
"from": "human",
"value": "What is the average pressure gradient (PG) across the left ventricular outflow tract (LVOT)?"
},
{
"from": "gpt",
"value": "2.8 mmHg."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What medications are being administered as part of the treatment plan?"
},
{
"from": "gpt",
"value": "The medications being administered are pertuzumab (PERJETA), trastuzumab-anns (KANJINTI), and docetaxel (TaxOTERE)."
},
{
"from": "human",
"value": "What is the purpose of the treatment plan?"
},
{
"from": "gpt",
"value": "The purpose of the treatment plan is to administer chemotherapy to a patient with a malignant neoplasm of overlapping sites of the left breast, specifically an estrogen receptor-positive cancer."
},
{
"from": "human",
"value": "What is the dosage of pertuzumab (PERJETA) being administered?"
},
{
"from": "gpt",
"value": "The dosage of pertuzumab (PERJETA) being administered is 420 mg."
},
{
"from": "human",
"value": "What is the patient's diagnosis?"
},
{
"from": "gpt",
"value": "The patient's diagnosis is a malignant neoplasm of overlapping sites of the left breast, specifically an estrogen receptor-positive cancer, classified as C50.812 and Z17.0 (ICD-10-CM)."
},
{
"from": "human",
"value": "Who authorized the treatment plan and released it for administration?"
},
{
"from": "gpt",
"value": "The treatment plan was authorized and released by Dr. Pooja Murthy, MD, and was released by Jane Oh, RN, on August 29, 2024."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What type of medical procedure was performed on a patient on January 8, 2025?"
},
{
"from": "gpt",
"value": "A Peripheral Nerve Block was performed."
},
{
"from": "human",
"value": "What type of monitoring was used to monitor the patient during the Peripheral Nerve Block on January 8, 2025?"
},
{
"from": "gpt",
"value": "The patient was monitored using heart rate, blood pressure, continuous pulse ox, and EKG."
},
{
"from": "human",
"value": "What was the reason for performing the Peripheral Nerve Block on January 8, 2025?"
},
{
"from": "gpt",
"value": "The Peripheral Nerve Block was performed for post-op analgesia, at the request of the surgeon."
},
{
"from": "human",
"value": "What type of equipment was used to perform the Peripheral Nerve Block on January 8, 2025?"
},
{
"from": "gpt",
"value": "The equipment used to perform the Peripheral Nerve Block included echogenic needles, and ultrasound equipment, which was used to guide the needle and capture an image of the procedure."
},
{
"from": "human",
"value": "What type of preparation was done before the Peripheral Nerve Block on January 8, 2025?"
},
{
"from": "gpt",
"value": "The patient was prepared with a chlorhexidine and sterile prep, gloves, and mask, and the anesthesiologist performed a timeout and pre-op evaluation and anesthesia consent with the patient."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the medication being administered to the patient?"
},
{
"from": "gpt",
"value": "The medication being administered is pertuzumab, specifically 420 mg in sodium chloride 0.9% solution, to be given intravenously."
},
{
"from": "human",
"value": "What is the diagnosis for the patient?"
},
{
"from": "gpt",
"value": "The diagnosis is a malignant neoplasm of overlapping sites of the left breast in a female, and it is estrogen receptor positive."
},
{
"from": "human",
"value": "What is the name of the treatment plan that this medication order is a part of?"
},
{
"from": "gpt",
"value": "The treatment plan is called \"Trastuzumab + Pertuzumab Adjuvant\"."
},
{
"from": "human",
"value": "How often is the medication to be administered?"
},
{
"from": "gpt",
"value": "The medication is to be administered once."
},
{
"from": "human",
"value": "Who electronically signed the order for the medication?"
},
{
"from": "gpt",
"value": "The order was electronically signed by Dr. Pooja Murthy."
},
{
"from": "human",
"value": "What is the status of the medication administration?"
},
{
"from": "gpt",
"value": "The medication administration is completed."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "When was the patient's last mammogram?"
},
{
"from": "gpt",
"value": "The patient's last mammogram was in 2024."
},
{
"from": "human",
"value": "Is the patient physically active?"
},
{
"from": "gpt",
"value": "No, the patient reports being inactive."
},
{
"from": "human",
"value": "What is the patient's age at the time of their first child?"
},
{
"from": "gpt",
"value": "The patient had their first child at the age of 23."
},
{
"from": "human",
"value": "How long did the patient breastfeed their child?"
},
{
"from": "gpt",
"value": "The patient breastfed their child for 8 months."
},
{
"from": "human",
"value": "Does the patient have difficulty paying living expenses?"
},
{
"from": "gpt",
"value": "Not very hard, according to the patient's report."
},
{
"from": "human",
"value": "How many minutes per session does the patient engage in exercise?"
},
{
"from": "gpt",
"value": "The patient reports exercising 0 minutes per session."
},
{
"from": "human",
"value": "How many days per week does the patient engage in exercise?"
},
{
"from": "gpt",
"value": "The patient reports exercising 0 days per week."
},
{
"from": "human",
"value": "Has the patient experienced food insecurity in the past year?"
},
{
"from": "gpt",
"value": "No, the patient has not experienced food insecurity in the past year."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "Who was the ordering provider for the medication palonosetron (ALOXI) injection?"
},
{
"from": "gpt",
"value": "The ordering provider was Dekyi, Tenzin, NP."
},
{
"from": "human",
"value": "What is the name of the medication that was administered to the patient on 09/19/24, and what was the dose and route of administration?"
},
{
"from": "gpt",
"value": "The medication administered was palonosetron (ALOXI) injection, with a dose of 250 mcg and an intravenous route."
},
{
"from": "human",
"value": "Who performed the administration of palonosetron (ALOXI) injection?"
},
{
"from": "gpt",
"value": "The administration of palonosetron (ALOXI) injection was performed by Kuar, Pamela, RN."
},
{
"from": "human",
"value": "What is the name of the medication that was administered subcutaneously to the patient on 09/19/24, and what was the dose and site of administration?"
},
{
"from": "gpt",
"value": "The medication administered was pegfilgrastim (NEULASTA ONPRO), with a dose of 6 mg and a subcutaneous route of administration at the left upper arm (back)."
},
{
"from": "human",
"value": "What is the name of the medication that was given 30 minutes prior to chemotherapy, and what was the dose and route of administration?"
},
{
"from": "gpt",
"value": "The medication given 30 minutes prior to chemotherapy was palonosetron (ALOXI) injection, with a dose of 250 mcg and an intravenous route."
},
{
"from": "human",
"value": "Who performed the administration of pegfilgrastim (NEULASTA ONPRO)?"
},
{
"from": "gpt",
"value": "The administration of pegfilgrastim (NEULASTA ONPRO) was performed by Kuar, Pamela, RN."
},
{
"from": "human",
"value": "What is the name of the medication that was discontinued due to unavailability, and what was the dose and route of administration?"
},
{
"from": "gpt",
"value": "The medication that was discontinued due to unavailability was methylPREDNISolone Na Suc (PF) (SOLU-Medrol) injection, with a dose of 125 mg and an intravenous route."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the patient's blood pressure?"
},
{
"from": "gpt",
"value": "The patient's blood pressure is 111/73 mmHg."
},
{
"from": "human",
"value": "How much contrast was given to the patient during the procedure?"
},
{
"from": "gpt",
"value": "A total of 3 cc of contrast was given to the patient."
},
{
"from": "human",
"value": "Who performed the echocardiogram?"
},
{
"from": "gpt",
"value": "Gabrielle Milfort performed the echocardiogram."
},
{
"from": "human",
"value": "Who interpreted the results of the echocardiogram?"
},
{
"from": "gpt",
"value": "The results of the echocardiogram were interpreted by Alexander Volodarskiy, MD."
},
{
"from": "human",
"value": "What is the patient's weight?"
},
{
"from": "gpt",
"value": "The patient's weight is 134 pounds."
},
{
"from": "human",
"value": "What is the age of the patient who underwent the procedure?"
},
{
"from": "gpt",
"value": "The patient who underwent the procedure is 42 years old."
},
{
"from": "human",
"value": "What type of medical procedure was performed on the patient?"
},
{
"from": "gpt",
"value": "A two-dimensional transthoracic echocardiogram with color flow and Doppler was performed."
},
{
"from": "human",
"value": "What is the patient's height?"
},
{
"from": "gpt",
"value": "The patient's height is 62 inches."
},
{
"from": "human",
"value": "What was used to improve assessment of LV (Left Ventricle) function during the procedure?"
},
{
"from": "gpt",
"value": "A contrast injection of Definity was used to improve assessment of LV function."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the diagnosis of the patient, and what is the extent of the disease?"
},
{
"from": "gpt",
"value": "The patient has been diagnosed with cT2-3N0 invasive ductal carcinoma of the left breast, which is a type of cancer that is poorly differentiated and has spread to the breast tissue. The extent of the disease is stage IIA, and the prognostic stage is IB."
},
{
"from": "human",
"value": "What is the assessment of diastolic parameters, and what does it indicate?"
},
{
"from": "gpt",
"value": "The assessment of diastolic parameters indicates that the patient's left ventricular diastolic function and filling pressures are normal. This suggests that the patient's heart is able to relax and fill properly during diastole, and that there is no significant diastolic dysfunction."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the diagnosis of the mass in the left breast?"
},
{
"from": "gpt",
"value": "The mass is consistent with the site of biopsy-proven carcinoma, and the diagnosis is left breast IDC/DCIS (invasive poorly differentiated ductal carcinoma and ductal carcinoma in situ)."
},
{
"from": "human",
"value": "What is the comparison to the mass's previous size?"
},
{
"from": "gpt",
"value": "The mass is slightly decreased in size from 2.8 x 1.8 x 0.8 cm."
},
{
"from": "human",
"value": "What is the size of the hypoechoic mass in the left breast at the 6:00 areolar margin?"
},
{
"from": "gpt",
"value": "The mass is 1.6 x 1.7 x 0.5 cm."
},
{
"from": "human",
"value": "What is the result of the 34-gene panel genetic testing?"
},
{
"from": "gpt",
"value": "The result is negative."
},
{
"from": "human",
"value": "What is the clinical T and N classification of the cancer?"
},
{
"from": "gpt",
"value": "The clinical T classification is T2-3, and the N classification is N0."
},
{
"from": "human",
"value": "What is the pathologic prognostic stage of the cancer?"
},
{
"from": "gpt",
"value": "The pathologic prognostic stage is IA/IB."
},
{
"from": "human",
"value": "What are the percentages of ER, PR, and HER2 in the cancer?"
},
{
"from": "gpt",
"value": "The percentages are ER 80%, PR 70%, and HER2 3+."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the patient's diagnosis?"
},
{
"from": "gpt",
"value": "The patient's diagnosis is a malignant neoplasm of overlapping sites of left breast in a female, which is estrogen receptor positive."
},
{
"from": "human",
"value": "What type of care is being provided to the patient to prevent a specific complication associated with the chemotherapy regimen?"
},
{
"from": "gpt",
"value": "Prophylactic myeloid colony-stimulating factor is being recommended to prevent the complication of febrile neutropenia."
},
{
"from": "human",
"value": "What is the risk associated with the chemotherapy regimen being administered to the patient?"
},
{
"from": "gpt",
"value": "The chemotherapy regimen carries a HIGH risk of febrile neutropenia, which is a serious complication that can occur in patients undergoing chemotherapy."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the purpose of administering EPINEPHrine (ADRENALIN) 1 MG/ML injection?"
},
{
"from": "gpt",
"value": "The purpose of administering EPINEPHrine (ADRENALIN) 1 MG/ML injection is to give for severe respiratory distress (wheezing, bronchospasm, stridor, oxygen saturation <90%) and/or >30% reduction in blood pressure from baseline caused by an infusion reaction."
},
{
"from": "human",
"value": "What is the indication for administering diphenhydrAMINE (BENADRYL) injection?"
},
{
"from": "gpt",
"value": "The indication for administering diphenhydrAMINE (BENADRYL) injection is for mucocutaneous symptoms (flushing, hives, itching), respiratory symptoms (dyspnea, wheezing, bronchospasm, stridor, oxygen saturation <90%), and/or >30% reduction in blood pressure from baseline caused by an infusion reaction."
},
{
"from": "human",
"value": "What is the status of the orders for EPINEPHrine (ADRENALIN) and diphenhydrAMINE (BENADRYL) injections?"
},
{
"from": "gpt",
"value": "The orders for EPINEPHrine (ADRENALIN) and diphenhydrAMINE (BENADRYL) injections have been discontinued."
},
{
"from": "human",
"value": "What is the relationship between the administration of Trastuzumab + Pertuzumab and the administration of EPINEPHrine (ADRENALIN) and diphenhydrAMINE (BENADRYL) injections?"
},
{
"from": "gpt",
"value": "The administration of Trastuzumab + Pertuzumab is associated with the administration of EPINEPHrine (ADRENALIN) and diphenhydrAMINE (BENADRYL) injections as a treatment for infusion-related reactions."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the indication for administering sodium chloride 0.9% flush, as per the order?"
},
{
"from": "gpt",
"value": "The indication for administering sodium chloride 0.9% flush is for low volume infusion (250 mL or less) to perform IV line clearance."
},
{
"from": "human",
"value": "What is the recommended volume of sodium chloride 0.9% flush to be administered for IV line clearance?"
},
{
"from": "gpt",
"value": "20 mL of sodium chloride 0.9% flush is recommended for IV line clearance."
},
{
"from": "human",
"value": "Who authorized the order for sodium chloride 0.9% flush?"
},
{
"from": "gpt",
"value": "The order for sodium chloride 0.9% flush was authorized by Dekyi, Tenzin, NP."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the name of the nurse who released the instance of the treatment order?"
},
{
"from": "gpt",
"value": "The instance of the treatment order was released by Oh, Jane, RN."
},
{
"from": "human",
"value": "What is the status of the treatment order?"
},
{
"from": "gpt",
"value": "The status of the treatment order is \"Completed\"."
},
{
"from": "human",
"value": "What are the indications for the chemotherapy treatment?"
},
{
"from": "gpt",
"value": "The chemotherapy treatment is indicated for a malignant neoplasm of overlapping sites of the left breast in a female patient who is estrogen receptor positive. The specific ICD-10-CM codes for this diagnosis are C50.812 and Z17.0."
},
{
"from": "human",
"value": "Who is the ordering provider for this treatment?"
},
{
"from": "gpt",
"value": "The ordering provider for this treatment is Murthy, Pooja, MD."
},
{
"from": "human",
"value": "What is the reason for holding chemotherapy treatment in this patient's case?"
},
{
"from": "gpt",
"value": "The chemotherapy treatment is being held due to concerns about the patient's platelet count being less than 100,000/mm3. The provider also wants to be notified if the patient's bilirubin level exceeds the upper limit of normal."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's genetic testing status?"
},
{
"from": "gpt",
"value": "The patient's genetic testing is negative."
},
{
"from": "human",
"value": "What are some of the potential risks and complications of the surgery that were explained to the patient?"
},
{
"from": "gpt",
"value": "The risks and complications of the surgery that were explained to the patient include infection, bleeding, hematoma, seroma, positive margins requiring further surgery, poor cosmesis, chronic pain, paresthesias, and wound complications."
},
{
"from": "human",
"value": "What is the patient's age and menopausal status?"
},
{
"from": "gpt",
"value": "The patient is 41 years old and premenopausal."
},
{
"from": "human",
"value": "What are the patient's breast cancer characteristics?"
},
{
"from": "gpt",
"value": "The patient's breast cancer is ER-positive (80%), PR-positive (70%), and Her2-positive (3+). The tumor measures 7mm and is located in the left breast."
},
{
"from": "human",
"value": "What type of surgery is the patient interested in?"
},
{
"from": "gpt",
"value": "The patient is interested in bilateral nipple-sparing mastectomies with possible lymph node biopsy and reconstruction/plastic surgery."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's current condition regarding neuropathy?"
},
{
"from": "gpt",
"value": "The patient has mild neuropathy, which has improved significantly from before and she is no longer using gabapentin."
},
{
"from": "human",
"value": "What is the patient's current breast cancer diagnosis, and what is its stage?"
},
{
"from": "gpt",
"value": "The patient's cancer is an estrogen receptor-positive, HER2-positive, stage IB breast cancer, specifically an infiltrating duct carcinoma."
},
{
"from": "human",
"value": "What is the patient's current complaint regarding her scalp?"
},
{
"from": "gpt",
"value": "The patient has an itchy scalp with dandruff, which is bothering her."
},
{
"from": "human",
"value": "Has the patient had any chemotherapy recently?"
},
{
"from": "gpt",
"value": "Yes, the patient had chemotherapy on August 8, 2024, and again on November 21, 2024, with albumin-bound PACLitaxel (ABRAXANE) chemo injection."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the purpose of checking the cavity for hemostasis after a surgical procedure?"
},
{
"from": "gpt",
"value": "Checking the cavity for hemostasis is done to ensure that there is no bleeding from the surgical site. This is an important step in preventing complications and ensuring a smooth recovery for the patient."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "Who performed the administration of the acetaminophen (TYLENOL) tablet on January 9, 2025, at 19:01?"
},
{
"from": "gpt",
"value": "The administration of the acetaminophen (TYLENOL) tablet was performed by Kavod, Sapir, RN, at 19:01 on January 9, 2025."
},
{
"from": "human",
"value": "What is the common side effect of ceFAZolin (ANCEF) IVPB?"
},
{
"from": "gpt",
"value": "The common side effects of ceFAZolin (ANCEF) IVPB include nausea, diarrhea, and rash."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the patient's current hemoglobin level, and what is the reference range for this value?"
},
{
"from": "gpt",
"value": "The patient's current hemoglobin level is 13.2 g/dL, and the reference range for this value is 11.7 - 15.3 g/dL."
},
{
"from": "human",
"value": "What is the patient's platelet count, and what is the reference range for this value?"
},
{
"from": "gpt",
"value": "The patient's platelet count is 225 x10(3)/uL, and the reference range for this value is 150 - 400 x10(3)/uL."
},
{
"from": "human",
"value": "What is the patient's creatinine level, and what is the reference range for this value?"
},
{
"from": "gpt",
"value": "The patient's creatinine level is 0.75 mg/dL, and the reference range for this value is 0.51 - 0.95 mg/dL."
},
{
"from": "human",
"value": "What is the estimated ejection fraction of the patient's left ventricle, and how was it measured?"
},
{
"from": "gpt",
"value": "The estimated ejection fraction of the patient's left ventricle is 60-65%. This value was estimated based on measurements and visual assessment, using the Philips Affiniti to measure global longitudinal strain, which was normal at -20.4%."
},
{
"from": "human",
"value": "What is the assessment of the patient's diastolic function, and what is the status of the patient's right ventricle?"
},
{
"from": "gpt",
"value": "The patient's diastolic function is normal, and the patient's right ventricle is normal in size and function."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What medications were administered to the patient during their office visit on 9/19/2024?"
},
{
"from": "gpt",
"value": "The patient received the following medications:\n\n1. DiphenhydrAMINE (BENADRYL) injection 25 mg\n2. Famotidine (PEPCID) injection 20 mg\n3. MethylPREDNISolone sod suc (SOLU-Medrol) injection 125 mg\n4. Acetaminophen (TYLENOL) tablet 650 mg\n5. Pertuzumab (PERJETA) 420 mg in sodium chloride 0.9 % 264 mL chemo IVPB\n6. Trastuzumab-anns (KANJINTI) 390 mg in sodium chloride 0.9 % 268.57 mL chemo IVPB\n7. Docetaxel (TaxOTERE) 125 mg in sodium chloride 0.9 % 506.25 mL chemo IVPB\n8. Pegfilgrastim (NEULASTA ONPRO) 6 MG/0.6ML injection 6 mg"
},
{
"from": "human",
"value": "Who ordered the Urinalysis, Complete W/Reflex Culture lab test?"
},
{
"from": "gpt",
"value": "The test was ordered by Pagsuguiron, Maria Jovie, NP."
},
{
"from": "human",
"value": "Who reviewed and acknowledged the lab results?"
},
{
"from": "gpt",
"value": "The lab results were reviewed and acknowledged by both Murthy, Pooja, MD and Pagsuguiron, Maria Jovie, NP."
},
{
"from": "human",
"value": "What was the result of the Urinalysis, Complete W/Reflex Culture lab test?"
},
{
"from": "gpt",
"value": "The final result of the lab test was abnormal. The exact abnormality was not specified."
},
{
"from": "human",
"value": "Were there any allergies or sensitivities noted in the patient's medical record?"
},
{
"from": "gpt",
"value": "No active allergies were noted in the patient's review of allergies."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "Are there any regional wall motion abnormalities noted in the left ventricle?"
},
{
"from": "gpt",
"value": "No, there are no regional wall motion abnormalities noted in the left ventricle."
},
{
"from": "human",
"value": "What is the result of the pulmonic valve examination?"
},
{
"from": "gpt",
"value": "The pulmonic valve is grossly normal, and there is no pulmonic valvular regurgitation."
},
{
"from": "human",
"value": "What is the assessment of the left ventricular diastolic function?"
},
{
"from": "gpt",
"value": "The left ventricular diastolic function is normal, and the filling pressures are also normal."
},
{
"from": "human",
"value": "Are there any abnormalities noted in the mitral valve?"
},
{
"from": "gpt",
"value": "No, the mitral valve is normal in structure and function. However, there is trace mitral regurgitation."
},
{
"from": "human",
"value": "What is the size of the aortic root at the level of the sinuses of Valsalva?"
},
{
"from": "gpt",
"value": "The aortic root is normal size at the level of the sinuses of Valsalva."
},
{
"from": "human",
"value": "What is the estimated ejection fraction of the left ventricle based on measurements and visual assessment?"
},
{
"from": "gpt",
"value": "The estimated ejection fraction of the left ventricle is between 60-65%."
},
{
"from": "human",
"value": "What is the result of the global longitudinal strain measurement on the Philips Affiniti?"
},
{
"from": "gpt",
"value": "The global longitudinal strain measurement is normal, measuring -20.4%."
},
{
"from": "human",
"value": "Are there any abnormalities noted in the right ventricular systolic pressure?"
},
{
"from": "gpt",
"value": "No, the right ventricular systolic pressure is normal."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What are the indications for administering diphenhydrAMINE (BENADRYL) injection?"
},
{
"from": "gpt",
"value": "DiphenhydrAMINE (BENADRYL) injection is administered to treat mucocutaneous symptoms (flushing, hives, itching), respiratory symptoms (dyspnea, wheezing, bronchospasm, stridor, oxygen saturation <90%), and/or >30% reduction in blood pressure from baseline caused by an infusion reaction."
},
{
"from": "human",
"value": "What is the purpose of administering EPINEPHrine (ADRENALIN) in this medical treatment plan?"
},
{
"from": "gpt",
"value": "EPINEPHrine (ADRENALIN) is administered to treat severe respiratory distress (wheezing, bronchospasm, stridor, oxygen saturation <90%) and/or >30% reduction in blood pressure from baseline caused by an infusion reaction."
},
{
"from": "human",
"value": "What is the relationship between Trastuzumab + Pertuzumab Adjuvant treatment and the administration of these medications?"
},
{
"from": "gpt",
"value": "Trastuzumab + Pertuzumab Adjuvant treatment is the underlying treatment plan for which these medications are administered. The medications are given as needed (PRN) to manage infusion-related reactions."
}
] |
[
{
"from": "system",
"value": "You are A VASTLY intelligent ARTIFICIAL INTELLIGENCE with DOMAIN-EXPERT KNOWLEDGE from a variety of fields.\nUSE your knowledge to be helpful and truthfully answer questions about the world."
},
{
"from": "human",
"value": "What is the normal range for Aspartate Aminotransferase (AST) levels in the blood?"
},
{
"from": "gpt",
"value": "The normal range for Aspartate Aminotransferase (AST) levels in the blood is 5 - 32 U/L."
},
{
"from": "human",
"value": "What is the indication for the CMPP testing that was performed?"
},
{
"from": "gpt",
"value": "The indication for the CMPP testing is a malignant neoplasm of overlapping sites of left breast in a female, estrogen receptor positive."
},
{
"from": "human",
"value": "Who reviewed the lab results for the glucose, plasma test?"
},
{
"from": "gpt",
"value": "The lab results for the glucose, plasma test were reviewed by Pagsuguiron, Maria Jovie, NP on 8/6/2024 17:13 and Murthy, Pooja, MD on 8/15/2024 13:22."
},
{
"from": "human",
"value": "What is the result of the glucose, plasma test?"
},
{
"from": "gpt",
"value": "The result of the glucose, plasma test is 85 mg/dL, which is within the normal range of 74 - 106 mg/dL."
},
{
"from": "human",
"value": "What is the normal range for Glucose, Plasma levels in the blood?"
},
{
"from": "gpt",
"value": "The normal range for Glucose, Plasma levels in the blood is 74 - 106 mg/dL."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "Is there a known family history of medical problems in the patient's parents?"
},
{
"from": "gpt",
"value": "No, there is no known family history of medical problems in the patient's parents."
},
{
"from": "human",
"value": "Who is the surgeon who evaluated the patient?"
},
{
"from": "gpt",
"value": "The surgeon who evaluated the patient is Dr. Jerry W. Chang, MD."
},
{
"from": "human",
"value": "Does the patient use tobacco products?"
},
{
"from": "gpt",
"value": "No, the patient has never used tobacco products, including smoking or smokeless tobacco."
},
{
"from": "human",
"value": "Does the patient use substances such as alcohol or drugs?"
},
{
"from": "gpt",
"value": "No, the patient has never used substances such as alcohol or drugs."
},
{
"from": "human",
"value": "Has the patient used vaping products?"
},
{
"from": "gpt",
"value": "No, the patient has never used vaping products."
},
{
"from": "human",
"value": "Has the patient had any previous anesthesia-related alerts or adverse events?"
},
{
"from": "gpt",
"value": "No previous anesthesia alerts or adverse events have been documented in the Epic system. However, it is recommended to check for alerts in legacy systems."
}
] |
[
{
"from": "system",
"value": "You are a helpful AI assistant."
},
{
"from": "human",
"value": "What is the date of the patient's office visit?"
},
{
"from": "gpt",
"value": "The date of the patient's office visit is September 19, 2024."
},
{
"from": "human",
"value": "What medications is the patient currently taking, and what are their dosages and administration instructions?"
},
{
"from": "gpt",
"value": "The patient is currently taking the following medications:\n\n* Buspirone 5 MG Tablet: Take by mouth.\n* Clindamycin Phosphate 1 %: Apply topically 2 times a day.\n* Dexamethasone 4 MG Tablet: Take 2 tablets (8 mg) 2 times a day for 2 doses the day before chemotherapy, then 2 times a day for 3 doses starting the evening after chemotherapy and daily for 2 doses on days 3 to 4 of each 21-day cycle, cycles 1 to 6.\n* Hydrocortisone 1 % cream: Apply topically 2 times a day.\n* Lidocaine HCl (Viscous): Apply every 2 hours as needed.\n* Loratadine (Claritin) 10 MG: Take 1 tablet (10 mg) by mouth daily as needed for allergic reaction."
},
{
"from": "human",
"value": "What is the patient's diagnosis date for anxiety and malignant neoplasm of the breast?"
},
{
"from": "gpt",
"value": "The patient's diagnosis date for anxiety and malignant neoplasm of the breast is May 2024."
},
{
"from": "human",
"value": "Was a chaperone present during the sensitive exam, and if so, who was it?"
},
{
"from": "gpt",
"value": "Yes, a chaperone was present during the sensitive exam. The chaperone's full name and title are Liangkun Wang, MA."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What is the result of the left ventricular systolic function test performed on 5/12/25?"
},
{
"from": "gpt",
"value": "The left ventricular systolic function is normal, with an EF (ejection fraction) of 66%."
},
{
"from": "human",
"value": "What is the condition of the aortic valve?"
},
{
"from": "gpt",
"value": "The aortic valve is normal in structure and function."
},
{
"from": "human",
"value": "What is the conclusion of the medical evaluation performed on 5/12/25?"
},
{
"from": "gpt",
"value": "The patient is medically stable for procedure."
},
{
"from": "human",
"value": "What is the status of the patient's blood pressure and pulse rate?"
},
{
"from": "gpt",
"value": "The patient's blood pressure is 117/83 mmHg, and the pulse rate is 60 beats per minute."
},
{
"from": "human",
"value": "What was given to the patient and their husband by Ye, Dongqing, RN on 5/28/2025?"
},
{
"from": "gpt",
"value": "An implant ID card was given to the patient and their husband."
},
{
"from": "human",
"value": "What is the result of the chart review performed by Park, Min Jin, PA on 5/22/2025?"
},
{
"from": "gpt",
"value": "No apparent contraindication to proceed with surgery was found based on the chart review."
}
] |
[
{
"from": "system",
"value": "u are ai asstant plz answr questions"
},
{
"from": "human",
"value": "What are the patient's medical history diagnoses?"
},
{
"from": "gpt",
"value": "The patient has been diagnosed with anxiety, gastroesophageal reflux disease, hyperlipidemia, and a malignant neoplasm of the breast."
},
{
"from": "human",
"value": "Does the patient have any known allergies?"
},
{
"from": "gpt",
"value": "No, the patient does not have any known allergies."
},
{
"from": "human",
"value": "What is the patient's ideal body weight, and what is their adjusted ideal body weight?"
},
{
"from": "gpt",
"value": "The patient's ideal body weight is 54.7 kg, which is equivalent to 120 lb 9.5 oz. Their adjusted ideal body weight is 57.3 kg, which is equivalent to 126 lb 5.7 oz."
},
{
"from": "human",
"value": "What medications is the patient currently taking as an outpatient?"
},
{
"from": "gpt",
"value": "The patient is currently taking busPIRone 5 MG Tablet, Clindamycin Phosphate 1 % Lotion, hydrocortisone 1 % cream, ketoconazole 2 % Shampoo, tamoxifen citrate 20 MG Tablet, and triamcinolone 0.1 % Cream."
}
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.